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“Fear less, hope more;  
eat less, chew more;  
whine less, breathe more;  
talk less, say more;  
hate less, love more;  
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The prevalence of obesity and type 2 diabetes has increased at an alarming rate in developed 
countries. It seems in the light of current knowledge that metabolic syndrome may not 
develop at all without NAFLD, and NAFLD is estimated to be as common as metabolic 
syndrome in western population (23 % occurrence). Fat in the liver is called ectopic fat, which 
is triacylglycerols within the cells of non-adipose tissue. Serum alanine aminotransferase (ALT) 
values correlate positively with liver fat proportions, and increased activity of ALT predicts 
type 2 diabetes independently from obesity. Berries, high in natural bioactive compounds, 
have indicated the potential to reduce the risk of obesity-related diseases. Ectopic fat induces 
common endocrine excretion of adipose tissue resulting in the overproduction of 
inflammatory markers, which further induce insulin resistance by multiple mechanisms. Insulin 
resistance inducing hyperinsulinemia and lipolysis in adipocytes increases the concentration of 
free fatty acids and consequently causes further fat accumulation in hepatocytes. Polyphenolic 
fractions of berries have been shown to reverse inflammatory reaction cascades in in vitro and 
animal studies, and moreover to decrease ectopic fat accumulation. 
The aim of this thesis was to explore the role of northern berries in obesity-related diseases. 
The absorption and metabolism of selected berry polyphenols, flavonol glycosides and 
anthocyanins, was investigated in humans, and metabolites of the studied compounds were 
identified in plasma and urine samples (I, II). Further, the effects of berries on the risk factors 
of metabolic syndrome were studied in clinical intervention trials (III, IV), and the different 
fractions of sea buckthorn berry were tested for their ability to reduce postprandial glycemia 
and insulinemia after high-glucose meal in a postprandial study with humans (V).  
The marked impact of mixed berries on plasma ALT values (III), as well as indications of the 
positive effects of sea buckthorn, its fractions and bilberry on omental adiposity and adhesion 
molecules (IV) were observed. In study V, sea buckthorn and its polyphenol fractions had a 
promising effect on potprandial metabolism after high-glucose meal. In the literature review, 
the possible mechanisms behind the observed effects have been discussed with a special 
emphasis on ectopic fat accumulation. The literature review indicated that especially tannins 
and flavonoids have shown potential in suppressing diverse reaction cascades related to 
systemic inflammation, ectopic fat accumulation and insulin resistance development. 
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1. INTRODUCTION 
About 70-80 % of type 2 diabetics have non-alcoholic fatty liver disease (NAFLD) (Targher et al. 
2007), and those obese subjects who tend to accumulate abdominal fat have an increased risk 
of cardiovascular diseases (Lakka et al. 2002). Normally other tissues than adipose tissue 
contain only small amounts of fat. Ectopic fat is defined by the deposition of triglycerides 
within cells of non-adipose tissue that normally contain only small amounts of fat, i.e. liver and 
other internal organs. Ectopic fat accumulation in the liver and skeletal muscles in humans is a 
critical determinant of insulin resistance and may predispose to the development of type 2 
diabetes. NAFLD can thus be regarded as the hepatic manifestation of metabolic syndrome. 
This phenomenon can be explained by the impaired insulin sensitivity of a fatty liver, which 
results in higher glucose  (Ryysy et al. 2000, Marchesini et al. 2001, Seppälä-Lindroos et al. 
2002), higher very low density lipoprotein (VLDL) production (Adiels et al. 2006, 2007) in the 
liver, and thus insulin resistance. Serum alanine aminotransferase (ALT) values correlate 
positively with liver fat proportions, and the increased activity of ALT predicts type 2 diabetes 
independently from obesity (Vozarova et al. 2002, Hanley et al. 2004, Sattar et al. 2004). 
Berries are known to contain high amounts of vitamins, phenolic compounds, trace elements, 
and fiber, as well as a beneficial fatty acid (FA) composition (Kalt et al. 1999). Some indications 
of the capability of berries to reduce the risk of certain diseases have lately emerged. Berry 
polyphenols form a group of compounds with a high potential to affect metabolic diseases and 
their risk factors. The absorption and metabolism of certain berry polyphenols was 
investigated in the original research in this thesis from human plasma and urine (I, II).  
Northern berries have been implicated in the reduction of risk factors associated with various 
obesity-related diseases from emerging metabolic syndrome to cardiovascular events 
(Johansson et al. 2000, Marniemi et al. 2000, Erlund et al. 2008). Mechanisms of action include 
the modulation of signalling pathways as well as antioxidative properties, although knowledge 
of the exact metabolic and inflammatory routes involved is only currently emerging. As part of 
the original research of this thesis three separate human trials were conducted to reveal the 
effects of berries on ectopic fat accumulation and the risk of diseases related to obesity. First, 
the effects of the daily consumption of black currant (Ribes nigrum), sea buckthorn 
(Hippophaë rhamnoides), bilberry (Vaccinium myrtillus), and lingonberry (Vaccinium vitis-idae) 
products on the risk factors associated with obesity-related diseases such as NAFLD were 
investigated (III). Further, in study IV, sea buckthorn berry, its fractions, and bilberry were 
studied alone as separate intervention periods to find out if there were differences between 
berries and different parts of the sea buckthorn berry. Also, sea buckthorn berry and its 
polyphenol-rich fraction were studied in a postprandial trial where a high-glucose meal was 
consumed with and without the berry (V). However, clinical trials conducted with whole berry 
products do not give an insight into which compounds or compound groups might be behind 
the observed effects. The complicated cascade from increased ectopic fat to hepatic steatosis 
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intertwined with various inflammatory and lipotoxic mechanisms present various potential 
action sites for berry polyphenols.  
A liver with high fat content also overproduces inflammatory markers such as sensitive C-
reactive protein (CRP), interleukin 6 (IL-6), and tumor necrosis factor α  (TNF-α) (Greco et al. 
2008). Berries seem to contain some anti-inflammatory compounds, as sea buckthorn 
(Hippophae rhamnoides var. Ljubitelskaja) has been shown to lower the sensitive C-reactive 
protein (hs-CRP) in a human trial (Larmo et al. 2007). Genes involved in inflammation are 
upregulated in subjects with a high fat content in the liver, and inflammation in subcutaneous 
adipose tissue is correlated with liver fat content independently of obesity. On the other hand, 
the polymorphism of several candidate genes have been associated with NAFLD. 
A net retention of lipids within hepatocytes is a prerequisite for the development of NAFLD. 
Visceral fat induces common endocrine excretion of adipose tissue (Mohamed-Ali et al. 1998), 
inducing the secretion of TNF-α, IL-6, plasminogen activator inhibitor-1, leptin, and 
angiotensinogen (Lakka et al. 2002), which further provokes insulin resistance by multiple 
mechanisms (Cohen et al. 1996). Insulin resistance induces hyperinsulinemia and lipolysis in 
adipocytes. The increased concentration of free FAs consequently causes further fat 
accumulation in hepatocytes (Angulo, 2002). Polyphenolic fractions of berries have been 
shown to reverse inflammatory reaction cascades in vitro and in animal studies. Especially 
tannins have shown potential in suppressing inflammation (Hou et al. 2007, Hwang et al. 
2009). 
In the literature review of this thesis the key metabolic dysfunctions leading to ectopic fat 
accumulation in overweight humans and obesity are described. Also, the effects of 
polyphenolic constituents found in northern berries on the detrimental impacts of a western 
lifestyle are reviewed.  
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2. REVIEW OF THE LITERATURE 
2.1. STRUCTURES AND OCCURRENCE OF BERRY PHENOLICS 
Berries are the small globular or ovate juicy fruits of herbs, shrubs or trees. Generally, berries 
are high in minerals and vitamins known to be vital for humans. Also, berries contain a wide 
spectrum of other compounds that have biological functions and affect human health. When 
the term berry bioactives is defined broadly it contains a very wide spectrum of different 
compound groups such as lipid compounds found in the seed and pulp oils of berries, 
polyphenols, sugars and acids, heteropolysaccharides commonly referred as insoluble fiber, 
cutins from the skin of the berries and soluble fiber like pectins. In this literature review the 
polyphenols of the berries are presented (chapter 2.1), and their effect on ectopic fat 
accumulation is discussed (chapter 2.3). 
The phenolic compounds act as protecting agents, and often condense in the cuticular surface 
layers of the plant. Berry polyphenols include flavonoids (anthocyanins, flavonols, and flavan-
3-ols), phenolic acids, stilbenoids, and tannins (condensed tannins and hydrolysable tannins). 
Phenolic compounds are important pigments in berries attracting birds and other animals 
involved in the pollination and seed dispersion (Faulds and Williamson 1999), and they are 
also involved in organoleptic properties of edible berries (Strack 1997). As phenolic 
compounds are part of the stress defence mechanism, their levels respond to environmental 
stress factors such as UV light (Ryan et al. 2001), and heavy metal toxicity (Kidd et al. 2001). 
Especially the flavonoid subclass seems to also protect leafs against photo-oxidative damage 
during senescence in the autumn (Felld et al. 2001). 
Polyphenols are a wide range of secondary metabolites synthesized through the shikimate 
pathway from the same intermediate, phenylalanine, or its precursor, shikimic acid (Harborne 
1989). The shikimic acid pathway begins with the condensation of phosphoenolpyruvate from 
glycolysis and erythrose 4-phosphate from the pentosephosphate pathway, and leads to the 
formation of the aromatic amino acids phenylalanine and tyrosine. Phenylalanine is the 
substrate for phenylalanine ammonia-lyase (PAL). Most phenolic compounds, such as 
phenylpropanoids are synthesized by the phenylpropanoid pathway, the first reaction of 
which the deamination of phenylalanine to cinnamic acid is catalyzed by PAL. The diversity of 
phenylpropanoids is produced from different branches of the central pathway converting the 
cinnamic acid by hydroxylation and esterification to 4-coumaric acid:CoA (Hahlbrock and 
Scheel 1989) which reacts with malonyl-CoA forming tetrahydroxychalcone, a precursor of 
diverse flavonoids. In addition, the complexity of phenolic structures arises from different 
modifications of the basic structures such as hydroxylation, methylation, and glycosylation. 
Gallic acid, galloylglucoses, gallotannins, and ellagitannins are synthesized from 3-
dehydroshikimate (Ossipov et al. 2003). Figure 1 shows the proposed biosynthetic 
relationships of the most common phenolic classes.  
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Figure 1: Biosynthesis of common phenolic groups. The phenylpropanoid pathway begins from the 
conversion of phenylalanine to cinnamic acid catalyzed by phenylalanine ammonia-lyase (PAL) and 
branches to the diverse polyphenol groups. Adapted from Winkel-Shirley et al. 2002.  
2.1.1. Flavonoids 
The basic structure of flavonoids is phenyl-benzo-γ-pyran, in which two aromatic rings are 
combined by a three-carbon chain. The synthesis of flavonoids is presented in Figure 1, and 
reviewed by Winkel-Shirley (2002). Flavonoids are derived in a plant from a chalcone 
structure, which is first converted to flavanones, dihydroflavonols, and flavan-3,4-diols. 
Further, flavan-3,4-diols are converted to flavonoid subclasses, namely flavonols, flavan-3-ols, 
proanthocyanidins, and anthocyanidins. Flavonols and flavan-3-ols are abundantly distributed 
among different branches of the plant kingdom. Anthocyanins are the red and blue pigments 
of plants, found abundantly in red and blue berries such as chokeberry (Aronia melanocarpa), 
bilberry (Vaccinium myrtillus), honeyberry (Lonicera kamchatka), black currant (Ribes nigrum), 
and blackberry (Rubus fruticosus) (Häkkinen and Törrönen 2000, Buchert et al. 2005). The 
basic structures of monomeric flavonoids are presented in Figure 2. Proanthocyanidins are 
discussed below in chapter 2.1.3.  
 
Figure 2: The basic structure of monomeric flavonoids. A=flavonol, B=flavan-3-ol, and C=anthocyanidin. 
R=OH, CH3. 
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2.1.2. Phenolic acids and hydrolysable tannins 
Phenolic acids can be divided into two groups, the derivatives of benzoic acid and the 
derivatives of cinnamic acid. Hydroxybenzoic acids are the constituents of hydrolysable 
tannins, the polymers of phenolic acids and simple sugars. Hydroxycinnamic acids exist as 
glycosylated and esterified forms (Manach et al. 2004). A hydroxycinnamic acid ferulic acid 
(Fig. 3A) is the most common phenolic acid in bilberry, chokeberry, and rowan berry (Häkkinen 
et al. 1999). Gallic acid (Fig. 3B) is a trihydroxylated benzoic acid which participates in the 
formation of hydrolysable tannins. Hydrolysable tannins are complex polymeric structures 
called gallotannins or ellagitannins (Fig. 3C) that hydrolyze into sugars, and gallic acid or ellagic 
acid (Bate-Smith 1972, Lei et al. 2001). Gallotannins are not universally distributed in higher 
plants, but occur in certain clearly defined taxonomic groups in both woody and herbaceous 
dicotyledons. On the other hand, ellagitannins are widely distributed in the lower taxons 
Hamamelidae, Dilleniidae, and Rosidae (Haslam, 1989). Rubus berries are the best known 
sources of ellagitannins (Serrano et al. 2009), but they are also found in nuts and many fruits 
such as pomegranate (de Pascual-Teresa et al. 2000). 
 
Figure 3: Structures of ferulic acid (A), gallic acid (B), and ellagitannin pedunculagin (C).  
2.1.3. Proanthocyanidins (condensed tannins) 
Plants synthesize proanthocyanidins from flavan-3-ols (Marles et al. 2003, Xie et al. 2004). 
Proanthocyanidins are polyhydroxyflavan oligomers or polymers. The structure of a simple 
trimeric prodelphinidin is presented in Figure 4. The monomeric flavanols differ in their 
hydroxylation pattern in ring A and B as well as in the stereochemistry of C-3. 
Proanthocyanidin classification is based on chemical structure and hydrolytically obtained 
anthocyanin monomer. Proanthocyanidins are believed to be ubiquitous, and it has been 
suggested that they account for a significant fraction of the polyphenols ingested in the 
western diet (Serrano et al. 2009). Fruits and berries are the best sources, but legumes, nuts 
and minority cereals also contain quite high amounts of proanthocyanidins. Proanthocyanidins 
tend to concentrate in the peel of fruits or the bran of grains, and the degree of 
polymerization being higher in the peel (Serrano et al. 2009). 
Review of the Literature 6 
 
Figure 4: Structure of a simple trimeric prodelphinidin. 
2.1.4. Stilbenes  
Stilbenes are hydroxylated trans-1,2-diphenylethylenes. The non-flavonoid polyphenolic 
structure is related to the synthetic estrogen diethylstilbestrol. The most widely investigated 
stilbene is resveratrol (Fig. 5), which is found in red wine, peanuts, and grapes (Alarćon de la 
Lastra and Villegas 2005), and is also present in small amounts in cranberry and bilberry 
(Manach et al. 2004). Resveratrol is mainly concentarted in the skin (Jeandet et al. 1991), and 
thus the content of resveratrol in wine depends on the contact time between the berry skin 
and the juice. 
 
Figure 5: Structure of the most common stilbene, resveratrol. 
2.1.5. Lignans 
Lignans are one of the two major groups of phytoestrogens, the other being isoflavonoids. 
Sesamin is the precursor structure for lignans such as matairesinol and secoisolariciresinol 
occurring in plants. Two enterolignans of mammals, enterodiol and enterolactone, are 
probably formed from plant lignans in the large bowel as rat studies have indicated (Penalvo 
et al. 2005a). Plant lignans in foods are mainly glycosides, and found especially in whole-
grains, beans, flaxseed, sesame seed, vegetables, berries, and some other fruits (Milder et al. 
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2005, Penalvo et al. 2005a and b, Thompson et al. 2006). The structure of matairesinol is 
presented in Figure 6. 
 
Figure 6: The structure of matairesinol. 
2.2. DEVELOPMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE  
2.2.1. Diagnostics of nafld 
The detection of NAFLD, liver fat content, possible histological changes related to NAFLD and 
disease activity is somewhat problematic, as the only equivocal means of diagnosis is liver 
tissue evaluation from biopsy. Laboratory tests such as alanine aminotransferase (ALT) and 
aspartate amino transferase (AST) are problematic due to the interindividual differences in 
relation to ALT/AST levels and fibrosis and cirrhosis progression (Neuschwander-Tetri et al 
2008). In addition, the upper limit of normal ALT values has been impugned recently 
(Greenfield et al. 2008). Imaging techniques indicate only the fat content of the liver, and do 
not detect disease activity. Ultrasound evaluation is accurate when >33 % of the liver is 
already affected (Saadeh et al. 2002), and computerised tomography and 1H-NMR (proton 
nuclear magnetic resonance) spectroscopy are not suitable for population screening due to 
radiation exposure or high cost. Thus, liver markers ALT and AST are currently by far the most 
commonly used of these methods. ALT values correlate positively with liver fat proportions 
(Greco et al. 2008), although the development of NAFLD cannot be excluded on the basis of 
normal ALT values. However, in persons with normal ALT values, even within the reference 
range, the level of the enzyme is higher in individuals with higher BMI.  
2.2.2. Ectopic fat accumulation in obesity  
FAs are synthesized mainly in liver from acetyl-CoA, althought most tissues can assemble 
triacylglycerols from acyl-CoAs and glycerol-3-phosphate. FAs are converted back to acetyl-
CoA by β-oxidation and used as fuel, and the synthesis and breakdown is regulated to meet 
the cellular energy needs. 
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The traditional perception of adipose tissue as a mere storage place for FAs has been replaced 
over the past years (Hajer et al. 2008). In addition to its role in insulating and cushioning the 
body and storing free fatty acids (FFA) after food intake and releasing FFAs during the fasting, 
the adipose tissue produces a wide range of hormones and cytokines involved in glucose 
metabolism, lipid metabolism, and feeding behaviour (Frühbeck et al. 2001) as well as in 
inflammation, coagulation, and blood pressure (Trayhurn and Beattie, 2001).  
When caloric intake is equal to caloric expenditure, the liporegulatory system is at rest, and 
the lean tissues contain little or no unmetabolized lipids. A prolonged positive energy balance 
promotes an increased mass of adipose tissue. Initially, adipose tissue grows primarily through 
increases in cell size (adipocyte hypertrophy) and subsequently cell number (adipocyte 
hyperplasia) (Rosen and MacDougall, 2006). During hyperplasia, adipocytes increase leptin 
secretion. These are antiobesity hormones that enhance lean tissue oxidation of surplus lipids 
by activating AMP-activated protein kinase and reducing the activity and expression of 
lipogenic enzymes (Unger et al. 2003a). These events combine to lower the hepatic 
concentration of malonyl coenzyme A, a metabolite of the FA synthesis and powerful inhibitor 
of carnitine palmityl transferase-1 (CPT-1)-mediated fatty acid β-oxidation (McGarry et al. 
1977). Leptin also reduces the expression of lipogenic enzymes such as acetyl-CoA carboxylase 
(ACC), fatty acid synthase (FAS), and glycerol-3-phosphate acyl transferase (Zhou et al. 1997). 
The combination of an increase in FA β-oxidation and a decrease in FA synthesis could account 
for the reduction in the lipid content of the cell (Unger et al. 2003a). The biochemistry of a 
normal liporegulation during overnutrition is presented in Figure 7. 
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Figure 7: The biochemistry of a normal liporegulation during overnutrition. Normally during 
overnutrition, increased leptin in the plasma maintains FA oxidation at an appropriate level, thus 
preventing lipotoxicity. The binding of leptin to its receptor initiates a phosphorylation cascade via the 
Janus kinase (Jak)/STAT-pathway. Phosphorylated STAT-3 enters the nucleus and regulates the 
transcriptional activity of its target genes. Its effects include the up-regulation of PGC-1α, which is 
involved in mitochondrial biogenesis, and the enzymes of FA oxidation, CPT-1 and ACO. It also down-
regulates lipogenic enzymes, such as ACC and FAS. Another important action of leptin is to phosphorylate 
AMPK, which activates it. AMPK phosphorylates ACC, which blocks malonyl coenzyme A formation, thus 
maintaining FA oxidation at a suitable level to prevent lipotoxic effects. (Adapted from Unger 2003a). 
ACO = acetyl-CoA oxidase, ACC = acetyl-CoA carboxylase, AMPK = adenosine monophosphate kinases, 
CPT-1 = carnitine palmityl transferase-1, FAS = fatty acid synthase, (Jak)/STAT-pathway = Janus kinase/ 
signal transducer and activator of the transcription pathway, STAT-3 = signal transducer and activator of 
transcription-3, PGC-1α = prostaglandin 1α.  
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However, ultimately the failure of adipocytes to appropriately buffer the plasma FA 
concentration can result in disturbances in the otherwise tightly regulated lipid content of 
non-adipocyte cells (Hill et al. 2009). Undoubtedly, adipocytes have evolved with the potential 
to store a significant quantity of TAG’s, because storage in non-specialist cells was not tenable 
due to the unavoidable pathogenic consequences (Unger et al. 2003a).  
As well as accumulation of lipid in non-adipocytes, obesity can lead to an increase in the 
volume of non-classical adipose depots, and to adipocyte infiltration into other tissues (Hill et 
al. 2009). Ectopic fat storage includes both intraabdominal visceral, omental, perivascular, 
pericardial, perirenal, and retroperitoneal adipose tissue expansions as well as intracellular 
(liver, skeletal, muscle, heart, pancreas, kidney, and other organs) fat deposition (Blüher, 
2009).  
Leptin deficiency- or dysfunction-induced abnormal liporegulation leads to ectopic fat 
accumulation as shown in Figure 8. There are remarkable interindividual differences on how 
fast the deterioration of liporegulation occurs during overnutrition. As leptin has a major 
regulatory role, defects in leptin signalling such as aleptinemic disorders, relative 
hypoleptinemia or leptin unresponsiveness give an early push towards lipotoxicity (Unger et 
al. 2003a). Adiponectin is a relatively lately identified secretory protein belonging to the 
collectin family and expressed by fat cells (Scherer et al. 1995). The expression of adiponectin 
is reduced in obese mice and humans. Adiponectin exists in the bloodstream as high-
molecular weight-, middle-molecular weight-, and low-molecular weight forms, of which high-
molecular weight oligomers have been shown to strongly negatively correlate with ectopic fat, 
thus possibly representing the form of adiponectin regulating lipid β-oxidation in liver and 
skeletal muscles (Kantartzis et al. 2009). 
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Figure 8: The biochemistry of abnormal liporegulation during overnutrition. When leptin action is lacking, 
the Jak/STAT pathway is not activated during chronic overnutrition. The high level of ACC expression and 
activity generates malonyl CoA, the lipogenic precursor and inhibitor of FA oxidation. More fatty acids 
and triacylglycerols are synthesized and less are oxidized, raising the triacylglycerols fatty acyl CoA 
content of lean tissues. (Adapted from Unger et al. 2003a). 
ACO = acetyl-CoA oxidase, ACC = acetyl-CoA carboxylase, AMPK = adenosine monophosphate kinases, 
CPT-1 = carnitine palmityl transferase-1, FA = fatty acid, FAS = fatty acid synthase, (Jak)/STAT-pathway = 
Janus kinase/ signal transducer and activator of the transcription pathway, STAT-3 = signal transducer 
and activator of transcription-3.  
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In the normal hepatocyte, energy received from the circulation of glucose, fructose, and lipids 
is stored as glycogen, and increased lipids are redistributed to peripheral tissues for 
combustion and storage in adipocytes (Anderson et al. 2008), and the hepatocellular lipid 
content remains below 5% (Leevy et al. 1962). When the excessive lipid overload in adipocytes 
leads to metabolic incompetence and macrophage infiltration (Anderson et al. 2008), in 
hepatocytes the consequences are organelle failure including mitochondrial dysfunction and 
endoplasmic reticulum (ER) and other organelle stress, as well as hepatic insulin resistance (de 
Ferranto et al. 2008). In the liver lipotoxicity appears to be induced mainly through ceramide 
formation, which increases inducible nitric oxide synthase (iNOS) (Shimabukuro et al. 1997). 
However, it must be noted that the triacylglycerol content of the liver is simply a biomarker of 
increased hepatic exposure to potentially toxic free FAs, and the interconversion of FFA into 
more stable TG is in fact the cell’s means of protection (Yamaguchi et al. 2007). 
2.2.3. Postprandial metabolism and ectopic fat  
2.2.3.1. Postprandial carbohydrate metabolism and ectopic fat accumulation  
Hormonal regulation of the carbohydrate metabolism is intertwined with the fat and protein 
metabolism. Insulin, as well as glucagon, somatostatin, and pancreatic polypeptide, are 
secreted by islets of Langerhans in the pancreas. Insulin is an anabolic and glucagon a catabolic 
hormone reciprocally regulating the intermediary metabolism of energy nutrients (Ganong, 
2003). The binding of insulin to its receptors in skeletal muscle and adipose cells normally 
triggers the tyrosine kinase activity of β subunit and further phosphorylation cascade which 
culminates into the translocation of the glucose transporter (GLUT4) from intracytoplasmic 
vesicles to the plasma membrane facilitating glucose absorption (Quon et al. 1994). 
Phosphorylation of some cytoplasmic proteins and dephosphorylation of others result also in 
various other tissue-specific and far-reaching effects of insulin. Insulin induces the expression 
of the enzymes of FA synthesis through upregulation of the lipogenic transcription factor, 
SREBP-1 (Foufelle and Ferré, 2002).  
The number and the affinity of insulin receptors are affected by exercise, food, and other 
factors. The number of receptors is decreased in obesity. Defects in the insulin metabolism 
have extensive and serious consequences. Traditionally, it has been thought that widespread 
biochemical abnormalities in diabetes can be solely traced to the reduced entry of glucose into 
various peripheral tissues and the increased liberation of glucose into the circulation by the 
liver (Ganong, 2003). However, it has also been proposed that glucometabolic insulin 
resistance is secondary to the overaccumulation of lipids (Boden and Schulman, 2002), and 
that resistance to insulin-stimulated uptake of surplus glucose might even be a defence 
against lipid overaccumulation in lean tissues, as glucose is a potent substrate of de novo 
lipogenesis (Unger et al. 2003b). Also, metabolic disorders are related to chronic low-grade 
inflammation (Shoelson et al. 2006), which is further discussed in chapter 2.2.4.  
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Postprandial plasma glucose levels depend largely on the rate of hepatic glucose uptake. Thus 
postprandial glucose metabolism is more strongly intertwined with ectopic fat accumulation 
than fasting plasma glucose values. NAFLD has been shown to be related to the 2-h or 1-h 
post-challenge glucose levels but not to fasting plasma glucose (Shiga et al. 2009). Storage of 
triacylglycerols in the liver following i.e. overeating leads to fat deposition in the hepatocytes 
and reduces insulin sensitivity of hepatocytes. An insulin resistant liver results in postprandial 
hyperglycemia (Kawamori et al. 2000). The impairment of the rapid pulsatile secretion of 
insulin provokes postprandial hyperglycemia further, which then may bring about the delayed 
hyper-secretion of insulin from β-cells. Delayed hyperinsulinemia increases ectopic fat 
accumulation thus closing the vicious cycle of NALFD with impaired glucose tolerance. 
It is undisputed that the type of food ingested affects postprandial sugar metabolism. It has 
been shown that diet rich in food items that result in a lower postprandial insulin response 
modulates the inflammation status (Kallio et al. 2008). Repeated high postprandial insulin 
response and early postprandial hyperglycemia increase oxidative stress (Ceriello et al. 2008), 
inflammation (Dandona et al. 2005), and possibly insulin resistance and β-cell dysfunction 
(Ludwig et al. 2002). High postprandial glycemia and insulinemia are also significant risk 
factors of cardiovascular diseases in patients with type 2 diabetes (Ginsberg et al. 2001). As 
Westerners spend most of their time in a postprandial state, it is important to focus on the 
metabolism of the fed state instead of fasting values only (Lairon et al. 2007).  
Ectopic fat accumulation requires an excessive input of lipids in one way or another. Increased 
dietary intake of energy, either as fat or carbohydrate, results in ectopic fat accumulation, as 
the overall fat mass increases. Despite the undisputed role of energy intake, the types of 
energy nutrients also have a major effect. A high glycemic index (GI) diet impairs fat β-
oxidation resulting in rapid-onset increase in body fat mass and liver fat in mice (Isken et al. 
2009). The gene expression profile is also consistent with elevated lipogenesis, and after the 
long-term exposure of a high-GI diet glucose clearance is impaired (Isken et al. 2009). Other 
short and long-term animal studies have shown similar results (Kabir et al. 1998, van 
Schothorst et al. 2009), and some indications of deteriorated fat β-oxidation and enhanced 
lipogenesis during a high-GI diet in humans exist (Lê and Bortolotti 2008). Even ingestion of 
different simple sugars results in a different kind of postprandial metabolism and thus shunt 
lipids differently towards ectopic reserves. For example fructose has been shown to increase 
postprandial triacylglycerol concentrations, decrease storage efficiency in adipose tissue, and 
eventually alter regional distribution of triacylglycerols towards ectopic fat accumulation, 
whereas glucose does not seem to have such impacts (Hoffman and Tschöp, 2009). Stanhope 
and Havle (2008) have extensively reviewed the effects of fructose consumption on visceral 
obesity, and they conclude that a diet high in fructose produces an oversupply of lipids within 
the liver via increased de novo lipogenesis. They also note that while the liver triacylglycerols 
accumulation is associated with disrupted insulin signaling, the exact downstream steps 
require further research. 
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2.2.3.2. Postprandial fat metabolism and ectopic fat accumulation 
Adipose tissue buffers the plasma free FA levels by avidly draining them from triacylglycerol-
rich lipoproteins in the postprandial state and gently releasing them in the fasting state. 
Adipose tissue failure is the state when lipids begin to accumulate in non-adipose tissues also. 
Lacrausta et al. (2007) have proposed that an initial failure of the adipose tissue to buffer 
postprandial lipids results in the loss of the functional activities of the adipose tissue, i.e. an 
organ failure. Adipose tissue failure can be either secondary, as is the case in type 1 diabetes 
when the lack of insulin is responsible for the adipose tissue dysfunction (Goldberg et al. 2001, 
Schwab et al. 2006) or primary when the excess of demands for the adipose tissue cannot be 
met due to chronically high food intake (Lacrausta et al. 2007).  
The type of fat ingested and other food components consumed, both on a short and long term 
basis, modify the postprandial lipemia after a particular meal. Lower postprandial lipemia is 
generally considered less atherogenic (Karpe 1999), and high postprandial lipemia probably 
stresses adipose tissue leading eventually to adipose tissue failure and ectopic fat 
accumulation. However, major controversies exist on how different types of dietary fat and 
carbohydrates affect postprandial lipemia. A low-fat and high-carbohydrate diet seems to 
deteriorate the blood lipid abnormalities while a high monounsaturated fat diet improves 
them (Jiménez-Gómez et al. 2010).  
In a parallel group intervention study in rats a polyunsaturated fatty acid (PUFA) rich diet 
protected from the steatosis (Buettner et al. 2006). PUFA enhances lipid β-oxidation and 
decrease lipid synthesis by modifying the expression of genes related to lipid metabolism 
(Buettner et al. 2006). On the other side, trans fats, common fast foods, and baked goods, 
cause non-alcoholic steatohepatosis (NASH) in sedentary mice (Tetri et al. 2008). Also, 
polyunsaturated fat supplementation attenuated the adverse effects of low-fat and high-
carbohydrate diet (Jiménez-Gómez et al. 2010). 
2.2.4. Ectopic fat and inflammation 
There are profound differences between visceral and subcutaneous adipocytes in the 
metabolism, as the expression of specific receptors, as well as the secretion of specific 
adipokines and many pro-inflammatory cytokines are predominantly secreted from visceral 
adipose tissue, whereas adiponectin is mainly expressed in subcutaneous fat (Motoshima et al. 
2002, Blühner 2008). The morphology of adipocytes in adipose tissue as well as in visceral 
adipose tissue defines the adipokine secretion pattern of the cell. Large, lipid-laden adipocytes 
often present in obesity (Pausova et al. 2006) secrete CRP, IL-6, monocyte chemotactic 
protein-1 (MCP-1), and plasminogen activator protein-1 (PAI-1) at higher levels compared to 
fat mass-matched controls with smaller fat cells (Blühner 2008). It can thus be proposed that 
adipocyte growth is the first push towards adipocyte dysmetabolism. Large adipocytes and 
increased adipose tissue mass in obesity lead to hypoxia, unless adequate vascularization 
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supports the vital functions of oxygen and nutrient transport (Trayhurn and Woods, 2004). 
This may contribute to cell level stress, and further to macrophage infiltration and 
inflammation (Blühner 2009). Experimental hypoxia has been shown to stimulate secretion of 
inflammation-related adipokines, including angiopoietin-like protein 4, IL-6, and vascular 
endothelial growth factor (Trayhurn et al. 2008).  
Large lipid-swollen adipocytes also suffer from other inflammation-related stresses in 
addition to hypoxia. Systemic oxidative stress characterizes the obese state (Rudich et al. 
2007), and metabolic stress may result from, for example, incomplete folding of 
synthesized proteins in the endoplasmic reticulum (Blühner 2009). Cells respond to such 
intracellular or extracellular stresses by activating numerous stress-responsive signalling 
pathways (Blühner 2009). Some of these signalling pathways include kinases dedicated to 
transmit stress response, like p38MAPK and c-Jun N-terminal kinases (JNK) (Blühner 
2009). These kinases are more expressed and more phosphorylated in omental adipose 
tissue than subcutaneous, and the phosphorylation degree correlates with metabolic 
parameters such as fasting triacylglycerols and glucose (Bashan et al. 2007). However, 
inflammation in subcutaneous adipose tissue is correlated with liver fat content 
independently of obesity (Kolak et al. 2007). 
Obesity-related hepatic fat accumulation is directly associated with the increased production 
of inflammatory cytokines (Dielh et al. 2005). A liver with a high fat content overproduces 
inflammatory markers such as hs-CRP, IL-6 and TNF-α (Kotronen and Yki-Järvinen, 2008). 
Genes involved in the inflammation are upregulated in subjects with a high fat content in the 
liver (Greco et al. 2008). Several intervention studies in humans (recently reviewed by 
Harrison, 2006) have shown that weight loss normalizes the cytokine levels. Also the 
carbohydrate metabolism is tightly intertwined with cytokine expression and metabolism, as 
hyperinsulinemia has for example been shown to increase both TNF-α mRNA in adipose tissue 
(Krogh-Madsen et al. 2004) and TNF-α concentrations in plasma (Ruge et al. 2009). 
Human adipose tissue, especially in obese states, is the target of macrophage infiltration 
(Weisberg et al. 2003). Macrophages may be recruited in response to death of hypertrophied 
fat cells (Cinti et al. 2005), and to the excessive secretion of pro-inflammatory cytokines (Curat 
et al. 2004). Also in the liver, cytokines are involved in the recruitment and activation of 
Kupffer cells, which are resident hepatic macrophages, and cause the transformation and 
perpetuation of hepatic stellate cells to the myofibroplastic phenotype (Friedman 2008). TNF-
α promotes activation of I κB kinase (IKK), which releases active NF-κB (nuclear factor kappa 
B), a proinflammatory “master switch” that regulates inflammatory mediators. Furthermore, 
TNF-α antagonices adiponectin, an anti-inflammatory adipocytokine, shift the balance even 
more into the direction of an inflammation. Macrophage infiltration into omental fat has been 
associated to the severity of the histological changes in liver biopsies (Cancello et al. 2006). 
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Eventually, inflammation contributes to the development of insulin resistance, which in turn 
further induces ectopic fat accumulation. Visceral fat induces common endocrine excretion of 
adipose tissue (Mohamed-Ali et al. 1998), including secretion of TNF-α, IL-6, plasminogen 
activator inhibitor-1, leptin, and angiotensinogen (Lakka et al. 2002). These products induce 
insulin resistance by multiple mechanisms. Leptin induces dephosphorylation of insulin-
receptor substrate-1 (Cohen et al. 1996). TNF-α, on the other hand, down-regulates insulin-
induced phosphorylation of insulin-receptor substrate-1, and reduces the expression of the 
insulin-dependent glucose-transport molecule GLUT4 (Hotamisligil et al. 1996). Insulin 
resistance inducing hyperinsulinemia and lipolysis in adipocytes increases the concentration of 
FFA and consequently causes further fat accumulation in hepatocytes (Angulo, 2002).  
2.3. PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE,    
METABOLIC SYNDROME  AND TYPE 2 DIABETES 
The prevalence of obesity, as well as associated diseases such as type 2 diabetes has increased 
at an alarming rate in developed countries. Metabolic syndrome and type 2 diabetes have 
acquired a lot of attention and aroused discussion worldwide, but fatty liver disease (non 
alcoholic fatty liver disease, NAFLD) has remained a relatively unrecognized manifestation of 
the syndrome among the general population. However, it seems in light of current knowledge 
that metabolic syndrome may not develop at all without NAFLD.  
Lipid deposition in the liver leads to NAFLD, and this may subsequently develop into nona-
lcoholic steatohepatitis (NASH). Steatosis, a histologic manifestation of intracytoplasmic 
lipid in the form of triacylglycerols in hepatocytes, is always present in NAFLD (Puri et al. 
2007). Tiniakos et al. (2010) have discussed different aspects of ectopic fat accumulation in 
their recent review on NAFLD. The intracytoplasmic fat can be either large droplets of 
macrovesicular fat that fill the cytoplasm of the hepatocyte, or more rarely, foci of 
hepatocytes with true microvesicular steatosis, i.e. a cluster of several hepatocytes. Mixed 
large and small droplets often occur in hepatocytes of NAFLD patients (Tiniakos et al. 2010). 
Dysregulation of lipid content in non-adipocytes can result in lipid-induced apoptosis 
(lipoapoptosis) and inflammation. Hepatocellular injury and lobular inflammation define 
NASH (Brunt, 2001). FFA lipotoxicity, oxidative stress, unfolded protein response, 
adipokine/cytokine effects, mitochondrial injury and inflammation result in histological 
lesions including megamitochondria (giant mitochondria), glycogenated hepatocyte nuclei in 
clusters, iron deposition within hepatocytes, ductural reaction (presence of hyperplastic 
ductural structures accompanied by varying amounts of inflammation and connective tissue 
at the portal tract interface), and Mallory-Deck bodies (Tiniakos et al. 2010).  Hepatocytes 
may suffer either necrotic or apoptotic death. Lytic necrosis is often preceded by 
hepatocellular ballooning resulting from microtubular disruption and from alterations to the 
intermediate filament cytoskeleton (Burt et al. 1998). TAG itself may not be directly involved 
in lipoapoptosis and has, in fact, been considered to be a protective agent (Listenberger et 
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al. 2003), but their hydrolysis to fatty acyl-CoA provides an amplified substrate for ceramide 
synthesis. Ceramide up-regulates iNOS expression, and thus leads to increased intracellular 
peroxynitrite, a candidate for lipoapoptosis (Bielawska 1997). 
Ford (2005) has concluded in his review that the increased prevalence of excessive visceral 
fat is closely associated with the rising incidence of type 2 diabetes, and the accumulation of 
lipids in the liver is well correlated with hepatic insulin resistance (Seppälä-Lindroos et al. 
2002). About 70-80 % of type 2 diabetics have NAFLD (Targher et al. 2007), and those obese 
subjects who tend to accumulate abdominal fat have an increased risk of cardiovascular 
diseases (Lakka et al. 2002). This phenomenon can be explained by the impaired insulin 
sensitivity of a fatty liver, which results in higher glucose (Ryysy et al. 2000, Marchesini et al. 
2001, Seppälä-Lindroos et al. 2002) and higher VLDL (Adiels et al. 2006, Adiels et al. 2007) 
production in the liver, and thus insulin resistance (Ryysy et al. 2000, Adiels et al. 2006). 
Lipotoxicity is also believed to cause the failure of pancreatic β-cells (Unger 2001). Initially β-
cells undergo hyperplasia compensating for the peripheral insulin resistance. Subsequently, 
they lose the glucose transporter-2 and glukokinase (Ohneda et al. 1995) and ultimately 
approximately 50% of the β-cells disappear through lipoapoptosis (Unger 2003a). 
When Reaven (1988) originally developed the concept of insulin resistance in 1988, he did not 
include any marker of obesity in his description. Today, however, central obesity is included in 
all criteria of metabolic syndrome used and it is clear that in most cases obesity is important 
for the development of many of the other metabolic syndrome components such as increased 
triacylglycerol, decreased HDL levels, and hypertension as concluded by Bruce (2009) in a 
recent review. In particular, increased abdominal adiposity is generally associated with high 
circulating triacylglycerols, low HDL-cholesterol, and high plasma concentration of apoB-
containing lipoproteins (Hill, 2009). Imaging studies with MRI and computed tomography have 
shown that it is the excess of intra-abdominal or visceral adipose tissue and not the amount of 
subcutaneous abdominal fat which is the key correlate of the metabolic abnormalities 
observed in overweight/obese patients (Bjönrtorp 1991, Pouliot et al. 1992, Goodpaster et al. 
2003, Matsuzawa et al. 1995, Nielsen et al. 1997). Moreover, visceral fat can be regarded as 
mechanistic link between the metabolic syndrome components as it induces adverse immune 
and metabolic disturbances (Bays, 2009). 
In the light of current knowledge it seems that metabolic syndrome may not develop at all 
without NAFLD (Kotronen et al. 2007), and NAFLD is estimated to be as common as metabolic 
syndrome in western populations (23 % occurrence) (Seppälä-Lindroos et al. 2002). NAFLD is 
commonly associated with obesity, insulin resistance, dyslipidemia, and type 2 diabetes, and 
can thus be regarded as the hepatic manifestation of metabolic syndrome (Angulo, 2002, 
Bugianesi and McGullough 2005, Day 2006, McGullough 2006), and the fat content of liver the 
correlates negatively with hepatic insulin sensitivity, even independently of obesity (Seppälä-
Lindroos et al. 2002). It has also been shown, that increased activity of ALT predicts type 2 
diabetes independently from obesity (Hanley et al. 2004). 
Review of the Literature 18 
Insulin normally inhibits the production of glucose and VLDL in the liver (Yki-Järvinen 2005). An 
insulin resistant liver over-produces glucose (Ryysy et al. 2000, Seppälä-Lindroos et al. 2002) 
and VLDL particles (Adiels et al. 2006), increasing triacylglycerol concentration in the blood and 
reducing the level of high-density lipoprotein (HDL) levels (Adiels et al. 2007). VLDL production 
is further provoked by increased the fat content of hepatocytes, as the liver exports surplus fat 
as VLDL (Hill, 2009). Pancreatic B-cells on the other hand, are not able to export fat as VLDL, 
and thus lipid overflow results in cell death (Unger, 2003b).  
The fat content of the liver in NAFLD patients can be decreased by weight loss (Tiikkainen et al. 
2003, Petersen et al. 2005, Larson-Meyer et al. 2006) and rosiglitazone-medication (Carey et 
al. 2002). A low-fat diet (Westerbacka et al. 2005) and physical activity (Larson-Meyer et al. 
2006) probably also have a positive effect, but extensive clinical interventions have not been 
performed to settle this. 
2.4. THE EFFECT OF BERRY POLYPHENOLS ON ECTOPIC FAT 
ACCUMULATION  
The role of nutrition in the progression of obesity-related diseases is nowadays recognized 
to be important. However, although diet evidently has a major role in the development and 
progression of NAFLD, it must be noted that genetic predisposition also plays a significant 
part, as polymorphism of several candidate genes have been associated with NAFLD (Day, 
2006). Many reaction cascades intertwine genetic and environmental factors into an 
outcome of health or disease. For example AMPK (adenosine monophosphate activated 
protein kinases)-SIRT1 (silent information regulator T1)-cascade serves as an indicator of 
cellular energy status and is thus important in the regulation of carbohydrate metabolism. 
The relationships of genetic and environmental factors, pathogenic changes and the onset 
of diseases are schematized in Figure 9 together with the regulation on AMPK.   
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Figure 9: The relationships of genetic and environmental factors, pathogenic changes and the onset of 
diseases intertwined by the AMPK-SIRT1 cascade. The proposed mechanism for the activation of LKB1 
and LKB1 target molecules by SIRT1. SIRT1 activation leads to LKB1 deacetylation and further binding to 
the STE20-realted adaptor protein (STRAD) and mouse embryo scaffold protein (MO25). The formation 
of the complex activates LKB’s kinase activity and it phosphorylates AMPK. The combination of 
overnutrition, inactivity, and genetic and other factors interact to produce a state of metabolic 
susceptibility that is proposed to lead to the dysregulation of AMPK, and thus further to mitochondrial 
dysfunction, insulin resistance, hyperinsulinemia, and abnormalities in the cellular lipid metabolism, such 
as modest increases in plasma triglycerols and ectopic lipid deposition in muscles and the liver. The 
transition from this preclinical stage to the clinically diagnosed metabolic syndrome to overt disease may 
take many years, and the rate of progression is determined by environmental factors such as diet and 
exercise. Adapted from Ruderman et al. 2010.  
AMPK = adenosine monophosphate kinases, CVD = cardiovascular diseases, LKB1 = serine threonine liver 
kinase B1, Mo25 = mouse embryo scaffold protein, NAFLD = non-alcoholic fatty liver disease, SIRT1 = silent 
information regulator T1, STRAD = STE20-related adaptor protein. 
2.4.1. The effect of polyphenols on glucose and fat metabolism  
The effect of carbohydrate composition on postprandial hyperglycemia and postprandial 
insulin response is commonly accepted (Ludwig 2000, Kallio et al. 2008). However, even 
though there is some emerging evidence of the ability of other than macronutrient 
components of food to alter postprandial sugar metabolism, such evidence is to date scarce 
and mainly produced by in vitro and animal trials. In a recent study, the inclusion of cinnamon 
in a rice pudding meal lowered the postprandial glucose response (Hlebowicz et al. 2007). 
Moreover, blueberries were reported to have potential in the attenuation of insulin resistance 
in an animal trial (DeFuria et al. 2009). Some exotic fruits or their phenolic extracts have also 
shown positive effects on sugar metabolism in animal models, as Zunino (2009) recently 
reviewed. Hanamura et al. have shown that crude aeriola polyphenol fraction had a preventive 
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effect on postprandial hyperglycemia (Hanamura et al. 2006). Cissus quandrangularis stem 
favourably modified plasma glucose and insulin levels in male rats fed a high fat-high fructose 
diet (Chidambaram et al. 2010). Yet, also controversial results have been reported. Gruendel 
et al. (2007) found that carob pulp preparation rich in polyphenols deteriorated postprandial 
glycaemic control. Thus it seems that food matrix and other components present can 
modulate the effect of polyphenols on glycemic response. 
Grape seed polyphenols improve fed state fat metabolism through the regulation of the bile 
acid pathway gene expression (Del Bas et al. 2005), and black-tea polyphenols suppressed 
postprandial hypertriacylglycerolemia by suppressing the lymphatic transport of dietary fat 
(Kobayashi et al 2009) in rats. In an in vitro trial, apple, but not wine, polyphenol extract dose-
dependently decreases the esterification of cholesterol and the enterocyte secretion of 
lipoproteins in Caco2/TC7-enterocytes (Vidal et al. 2005). Consuming a strawberry product 6 
weeks in advance and with a high-fat meal mitigated fed-state oxidative stressors such as LDL 
oxidation and hyperlipemia in a placebo-controlled human trial (Burton-Freeman et al. 2010). 
Animal and in vitro studies have investigated which mechanisms might be behind the 
observed regulatory effects on the carbohydrate and fat metabolism of polyphenols. The 
ability of polyphenols to inhibit the activity of digestive enzymes probably has some 
contribution to the smoothing effects on postprandial glycemia and lipemia. Anthocyanins for 
example inhibit endopeptidases, ellagitannins α-amylases, and flavanols inhibit the activity of 
pancreatic lipase (McDougall et al. 2005). Glycosylated flavonoids also compete with sugars in 
absorption as they are able to attach Na+/glucose-transporters (Ruel et al. 2007).  
In addition, phenolic compounds seem to exert specific regulatory effects on reaction cascades 
related to insulin secretion and lipid homeostsatis. Anthocyanins enhance insulin secretion in 
pancreatic β-cells, and to reduce liver triacylglycerols, and plasma cholesterol in C57BL/6-mice 
(Jayaprakasam et al. 2006). It seems that all these effects can be traced to common regulatory 
mechanisms. AMPK serves as a sensor of cellular energy status, being activated by increased 
AMP/ATP-ratio or by upstream kinase, LKB1 (the tumor suppressor kinase) (Shaw et al. 2004, 
Shaw et al. 2005), CaMKKβ (Ca2+ /calmodulin-dependent protein kinase kinase β) (Hurley et al 
2005), and TAK1 (transforming growth factor-β-activated kinase-1) (Xie et al. 2006). The molecular 
physiology of a normal and lipotoxic liporegulation is described in more detail in Chapter 2.2.2. 
Here, the effects of polyphenols on AMPK phosphorylation cascade are described. Hyperglycemia 
induces dysfunction in hepatic AMPK leading to hepatic lipid accumulation and hyperlipidemia 
(Zang et al. 2004, Zang et al. 2006). The role of AMPK as the guardians of cellular energy 
homeostasis has been reviewed extensily by Hardie (2007). Thus, it has been stated that AMPK 
maintains the balance between ATP production and consumption in all eukaryotic cells (Hardie, 
2007). In the liver, AMPK inhibits the production of glucose, cholesterol and triacylglycerols and 
stimulates FA β-oxidation (Schimmack et al. 2006).  
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Polyphenols strongly stimulate AMPK (Zang et al. 2006), similarly to metformin (Shaw et al. 
2004, Zang et al. 2004,), which results in attenuated hyperlipidemia and atherosclerosis in 
diabetic mice (Zang et al. 2006). Hwang et al. (2009) have recently reviewed the natural 
compounds stimulating AMPK, and they pointed out polyphenols as active components of 
natural products. Evidence was most abundant concerning resveratrol, tannins, curcumin, and 
quercetin (Hwang et al. 2009). In endothelial cells, AMPK activation induced by EGCG reduced 
endothelin-1, a known vasoconstrictor (Reiter et al. 2010). The mechanism by which 
polyphenols exert AMPK activation has been further studied in vitro in human hepatocytes 
(Hou et al. 2008), and a proposed scheme involving SIRT1 and LKB1 is presented in Figure 10. 
Polyphenols
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Figure 10: A proposed scheme of the mechanism by which polyphenols exert AMPK activation involving 
SIRT1 and LKB1. SIRT1-activating polyphenols, stimulate LKB1 phosphorylation as well as AMPK 
phosphorylation and activation. AMPK activation in turn increases ACC phosphorylation and thus inhibits 
ACC activity. As a consequence, decreased production of malonyl-CoA results in the up-regulation of FA 
β-oxidation as well as down-regulation of fatty acid synthesis, thereby leading to hepatocyte lipid 
reduction. Also, activation of AMPK by polyphenols inhibits glucose-induced expression of FAS, which 
contributes to the reduction in triacylglycerols through inhibition of fatty acid biosynthesis. Adapted from 
Hou et al. 2008. 
AMPK = AMP-activated protein kinase, FA = fatty acid, FAS = fatty acid synthase, SIRT1 = silent 
information regulator T1, a mammalian ortholog of Sir2 (silent information regulator 2).  
2.4.2. Polyphenols and inflammation 
The inflammatory response is a complex self-limiting process coordinated by vasoactive 
amines, adhesion molecules, lipid-derived eicosanoids, cytokines, and chemokines as reviewed 
by Lawrence et al. (2002). When the self-limiting nature of this protective mechanism is 
inappropriately regulated, it is transformed into a detrimental, chronic state of inflammation. 
The increase in inflammatory tonus is mainly the result of lifestyle and nutritional habits, 
making the increase controllable as concluded by Bengmark (2006) in his review on nutrition 
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and chronic diseases. The potential effects of polyphenols on inflammation are extensively 
investigated, although most studies are of in vitro design, mainly cell cultures of human or fat 
cell lines. Major pathways and other inflammatory mechanisms as well as the effects of 
polyphenols on their function, are presented below. 
2.4.2.1. Polyphenols and the arachidonic acid pathway 
Arachidonic acid is released from membrane phospholipids through phospholipase A2 
cleavage, and can be metabolized by the cyclooxygenase pathway into prostaglandins and 
thromboxan A2 or by the lipoxygenase pathway to hydroperoxyeicosatetraenoic acids, 
hydroxyeicosatetraenoic acids, and leucotrienes (Needleman et al. 1986). Dietary polyphenols 
have inhibited the activity of cyclooxygenases, lipoxygenases and phospholipase A2 resulting in 
lower circulating levels of inflammatory eicosanoids in vitro (Baumann et al. 1980, Welton et 
al. 1986, Laughton et al. 1991). In addition to flavonoids (Laughton et al. 1991, Kim et al. 1998, 
Miles et al. 2005), tannins (Hong et al. 2001, Kundu et al. 2003, Hou et al 2007) have been 
shown to suppress cyclooxygenase and lipoxygenase activities in in vitro and animal studies. In 
structure-activity studies the galloyl moiety of the tannins rich in green tea appeared 
important in their inhibitory actions (Hou et al. 2007). It seems that the inhibitory effects of 
polyphenols is exerted mainly via gene expression modulation (Petroni et al. 1997, Moreno et 
al. 2003). 
2.4.2.2. Polyphenols and nitric oxide synthase 
A small amount of nitric oxide (NO) is essential for the maintenance of body functions, but 
significant increase in NO synthesis by inducible nitric oxide synthase (iNOS) invokes the 
inflammatory process (Nathan et al. 1992). Versatile polyphenols including apigenin, luteolin, 
kaempferol, myricetin, quercetin, and genistein, down-regulate iNOS enzyme expression 
and/or inhibit the iNOS enzyme activity in vitro (Kim et al. 1999, Wadsworth et al. 1999, Chen 
et al. 2001). Also tannins inhibit iNOS, and their ability to interfere with NOS action has been 
traced to the gallate structure of epigallocatechingallate (EGCG) in structure-activity studies 
(Chan et al. 1997). Moreover, anthocyanins may induce other forms of NOS, thereby 
ameliorating endothelial dysfunction and harmonizing blood pressure (Xu et al. 2004). 
Endothelial nitric oxide synthase (eNOS) plays an important role in maintaining blood pressure 
homeostsasis and vascular integrity, implying that flavonoids may protect against 
cardiovascular diseases by acting as vasodilatants (Xu et al. 2004). Also, EGCG has been shown 
to modulate the activity of different NOS isoforms with a net effect of decreased inflammation 
but enhanced NO synthesis in tissues like endothelium where it is needed (Sutherland et al. 
2005).  
Inhibition of iNOS expression seems to be mediated by the inhibition of IKB kinase, NF-κB and 
the STAT1-pathway (Chen et al. 2005), implying that iNOS regulation of polyphenols is 
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intertwined with the various other metabolic effects of polyphenols related to ectopic fat 
accumulation.  
2.4.2.3. Polyphenols, NF-κB pathway modulation and cytokine system 
Cytokines, the major mediators of local, intracellular communication, define the outcome of 
disease through a balance between pro-inflammatory (i.e. IL-6, IL-8, IL-2, TNF-α, IL-1β, IFN-γ) 
and anti-inflammatory (i.e. IL-10, IL-4, TGFβ) cytokines (Santangelo et al 2007). Phenolic 
compounds have been shown to be able to selectively interfere with cytokine production 
and/or function. For example, quercetin (Comalada et al. 2006) and catechins (Crouvezier et 
al. 2001) inhibit TNF-α and IL-6, simultaneously induce IL-10 release, and thus evoke the anti-
inflammatory effect. Resveratrol has been shown to suppress cytokine production in vivo in rat 
lungs (Birrell et al. 2005).  
The production of cytokines is coordinated by complex reaction pathways, one of the major 
ones being NF-κB, which regulates the induction of several pro-inflammatory cytokines mainly 
at the gene expression level, as well as chemokines, adhesion molecules, growth factors, 
acute-phase proteins, cell proliferation, migration, invasion, iNOS, and immuno-receptors 
(Nam et al. 2006). The inhibition of NF-κB can thus be considered a potent therapeutic anti-
inflammatory target (Karin et al. 2004). Resveratrol especially in its cis form is able to 
attenuate the expression of the NF-κB family of genes (Leiro et al. 2005). Tannins have been 
widely studied, and have been shown to suppress NF-κB cascade by acting at multiple steps of 
the activation process. NF-κB stimulators induce IκB proteins to be phosphorylated by IκB 
kinase, IKK, which releases the regulatory subunit of IκB, NF-κB. The released NF-κB 
translocates into the nucleus and modifies transcription into inflammatory direction (Hansen 
et al. 1994). EGCG inactivates IKK and the release of the NF-κB subunit (Wheeler et al. 2004, 
Aneja et al. 2004, Ichikawa et al. 2004). Also the anti-inflammatory effects of quercetin seem 
to be due to the inhibition of NF-κB subunit release from IκB as many in vitro studies have 
indicated this (Chen et al. 2005, Min et al. 2007, Garcia-Mediavilla et al. 2007). 
2.4.2.4. Polyphenols and the MAPK pathway 
The mitogen activated protein kinase (MAPK) pathway is a sequence-specific transcription 
factor providing assistance to NF-κB (Karin, 1995). The MAPK family consists of Ser/Thr 
kinases including in mammalian cells at least extracellular signal-regulated kinases ERK1/2, 
c-Jun amino-terminal kinases JNK 1/2/3, p38-MAP kinase, and ERK5 kinases, of which the 
JNK and p38 cascades are most involved in inflammation (Mayor et al. 2007). A perspective 
of the modular activators, intermediate effectors and downstream substrates specifying 
some of the pato-physiological effects of the p38 cascade are presented in Figure 11. 
Kaempferol, chrysin, apigenin, and luteolin inhibited ERK, JNK, and p38 in respiratory 
epithelial cells (Chen et al. 2004). Luteolin inhibited more specifically only ERK1/2 and p38 
(Xagorari et al. 2002), quercetin had an inhibitory effect on ERK and JNK (Huang et al. 2006), 
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and catechin inhibited p38, and JNK (Xagorari et al. 2002). Cyanidin-3-O-glucoside inhibited 
ERK1/2 (Pergola et al. 2006), and delphinidin and cyanidin prevented p38 and JNK activation 
in human aortic vascular smooth muscle cells (Oak et al. 2006). The effects of resveratrol on 
the inflammatory MAPK pathway was recently reviewed by Rahman et al. (2006) and they 
concluded that resveratrol seems to inhibit MAPK in some cells, but induce it in others. Also, 
the effects are dose dependant as lower concentrations are generally stimulatory and higher 
inhibitory, although the threshold differed between cell types. On the other hand, widely 
investigated EGCG elicits extensive anti-MAPK activity in various cell models (Wadsworth et 




















Figure 11: A perspective of the activators, intermediate signal mediators (MAP3K; MKK1-4, ASK and 
MAP2K;MKK6/MKK3), downstream substrates (MK2/3/5, ATF2, MEF2C, EE1A, EGFR), and patho-
physiological effects of the p38 cascade. Adapted from Mayor et al. 2007. 
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2.4.3. Polyphenols, fat deposition in the liver and pathophysiological 
consequences 
Pomegranate flower ethanol extract is rich in polyphenols, in particular ellagitannins, and has 
been shown to possess hepatoprotective effects when administered to rats prior to ferric 
nitrilotriacetate exposure (Kaur et al. 2006). The extract attenuated both the elevation of liver 
enzymes, and the histopathological effects of ferric nitriloacetate administration such as 
ballooning degeneration, fatty changes, and necrosis. Also, the polyphenol extract of 
fenugreek seeds, a common spice in India, alleviated ethanol-induced collagen and lipid 
accumulation in rat liver similarly to silymarin (Kaviasaran et al. 2007). In both studies, 
polyphenol extracts concurrently improved plasma lipids by lowering triacylglycerols, 
cholesterol and FFA (Kaur et al. 2006, Kaviasaran et al. 2007). In high fat-high-fructose fed rats 
the stem extract of Cissus quandrangularis inhibited the activation of hepatocellular enzymes, 
inhibited lipid deposition in the liver, attenuated the decline in antioxidant status, as well as 
elevation in lipid peroxidation and protein carbonyl in the liver (Chidambaram et al. 2010). 
Hibiscus sabdariffa extract rich in anthocyanins, flavonoids and protocatechuic acid decreased 
high-fat diet induced plasma lipid abnormalities such as high LDL cholesterol, as well as 
attenuated lipid accumulation in the liver (Yang et al. 2010). The effects were probably due to 
AMPK expression activation also observed in the study, as AMPK activation has previously 
been indicated to have a pivotal role in lipid metabolism (Hardie, 2007).  
Blueberries attenuated hepatic fibrosis measured as serum hyaluronic acid and ALT levels as 
well as fibrotic changes measured directly from the liver by staining after the rats were killed 
(Wang et al. 2010). Resveratrol inhibits non-alcoholic fatty liver disease in rats (Bujanda et al. 
2008).  
Despite the promising results in animal studies, human data is still scarce. However, some 
human trials exist and sea buckthorn extract has shown hepatic fibrosis alleviation in human 
cirrhotic patients in a 6 months intervention (Gao et al. 2003). 
2.5. SUMMARY 
Polyphenols constitute a large group of compounds with relatively versatile structures and 
ubiqitous prevalence in the plant kingdom. Polyphenols condense in the surface layers of 
plants, thus existing as high amounts on small berries with high surface-to-volume ratio. 
Berries are known to be generally healthy and lately more and more indications of their ability 
to sustain health has emerged. In the literature part of this thesis, the effects of polyphenols 
on ectopic fat accumulation was discussed by presenting the berry polyphenols and ectopic fat 
accumulation as biochemical and pathological process as well as reviewing the research 
performed on polyphenols and ectopic fat accumulation. 
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The review of the research performed this far on polyphenols and ectopic fat accumulation 
and related metabolic disturbances revealed indications that various polyphenol subclasses 
have the potential to affect metabolic diseases and their associated variables. Tannins, 
resveratrol, and flavonols are polyphenolic compounds and compound groups most 
investigated in regard to metabolic diseases. Of tannins, mainly epigallocatechins found in 
green tea have been in the focus of research. It can be concluded, that polyphenols have in 
many studies shown the potential to have a positive effect on ectopic fat accumulation and 
related dysfunctions such as whole-body inflammation.  
However, studies made with individual polyphenols found in berries are scarce and further 
investigation is needed to conclude whether or not polyphenols are the most active 
compound group in berries when the effects on ectopic fat accumulation are considered. 
Nonetheless, at this point it can be noted that polyphenols and especially the subgroups 
flavonols and tannins do pose a high potential. 
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3. AIMS OF THE STUDY 
The overall aim of this thesis was to study whether the incorporation of berries into the diet as 
i) whole berries, ii) industrially produced berry products, and iii) different industrially 
developed berry fractions could decrease the risk of obesity-related diseases.  
The aims of the studies included in this thesis fall into three groups. 
The first aim was to develop, optimize, and apply high performance liquid chromatography 
tandem mass spectrometry analysis of anthocyanins and flavonol glycosides and their 
metabolites to analyze the absorption and metabolism of these compounds in humans. (I, II) 
The second aim was to study the effect of a mixed berry diet on the risk factors associated 
with obesity-related diseases, and to find out which berries and berry fractions held the most 
potential. (III, IV) 
The third aim was to define how sea buckthorn berry and its extraction residues from food and 
nutraceutical industry affect the postprandial glucose metabolism. (V)  
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4. SUBJECTS, MATERIALS, AND METHODS 
4.1. STUDY DESIGNS AND ETHICAL CONSIDERATIONS 
Studies I and II were conducted as acute postprandial absorption studies, whereas studies III, 
IV, and V, were conducted as a randomized parallel intervention design (study III) or 
randomized cross-over design (studies IV, and V). The studies were conducted according to the 
guidelines laid down in the Declaration of Helsinki (2000), and all procedures involving human 
subjects were approved by the Ethics Committee of the Hospital District of Southwest Finland. 
Written informed consent was obtained from all subjects. The study products used in the 
studies were safe, traditional berry products. 
In studies I and II the study subjects consumed berries with yoghurt, and the absorption of 
polyphenols, anthocyanins in study I and flavonol glycosides in study II, was monitored 
compared to the baseline in either urine (study I) or in plasma, feces, and urine (study II). 
Study III was conducted as a randomized 20-week dietary intervention trial with two parallel 
treatment groups; lifestyle intervention with various berry products (berry group, n=31), or 
lifestyle intervention (control group, n=30). Physical measurements were made and blood 
samples were analysed from both groups both before and after the intervention. Study IV was 
a randomized cross-over intervention study with four berry diets (diets: SB, sea buckthorn; 
SBe, sea buckthorn extract; SBo, sea buckthorn oil; and BB, bilberry) and five wash-out periods 
before and after each berry intervention period. Study V was a postprandial randomized cross-
over study with three test meals (meals: B1, sea buckthorn berries; B2, berry residue extracted 
by SF-CO2; and B3, berry residue extracted by ethanol after SF-CO2 extraction), and a control 
meal (meal A).  
4.2. STUDY PRODUCTS AND TEST MEALS 
The berries used in the studies were lingonberry (studies I, II, and III), sea buckthorn (studies I, 
II, III, IV, and V), bilberry (studies III, and IV), and black currant (study III). Berries were used as 
frozen whole berries (studies I, II, III, and IV) as well as various berry products (studies III, IV, 
and V).  
In absorption studies, berries [lingonberry Vaccinium vitis-ideae) in studies I and II and sea 
buckthorn (Hippophaë rhamnoides ssp. mongolica var. Ljubitelskaja) in study II] were 
consumed as whole berries with vanilla youghurt.  
In study III, the subjects in the berry group consumed 3 portions of berry products daily 
equalling to 163 g of fresh berries (1138 g/week), and a weekly dose of 3.5 g of berry oils 
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(equalling to 245 g of berries). Daily berry products were selected from 18 berry products 
according to a specific product utilisation cycle, and consumption was recorded in a diary. The 
berry products were designed to replace other snack products in the diet. The berries used as 
ingredients were lingonberry, sea buckthorn berry (Hippophaë rhamnoides, ssp. mongolica, 
var. Ljubitelskaja), bilberry (Vaccinium myrtillus), and black currant (Ribes nigrum). The berry 
products were processed by five Finnish food enterprises on their commercial production 
lines.  
In study IV the bilberries were frozen whole berries (BB) and the sea buckthorn berries 
(Hippophaë rhamnoides ssp. turkistanica) were air-dried after harvesting (SB). Oils were 
extracted from berries (berry oil) and seeds (seed oil) with supercritical CO2. The sea buckthorn 
oil used in the study was a standardized product containing both berry oil and seed oil (SBo). 
After CO2 extraction, the residues were further extracted with 50% aqueous ethanol at 50 ˚C 
for phenolic compounds. After removal of ethanol, the phenolic extract was spray-dried at 60-
70 ˚C into a free-flowing powder with the aid of maltodextrin DE 6. The phenolic extract 
powder used in the study (SBe) contained native sea buckthorn extract and maltodextrin DE 6 
at a ratio of 1:1. All berry diets in study IV were designed to correspond to 100 g of berries 
daily.  
In study V the berries were consumed again in the yoghurt. Sea buckthorn (Hippophaë 
rhamnoides L. ssp. turkestanica) berries were used as dried whole berries (B1). The crushed 
whole berries were extracted by supercritical CO2 to obtain berry residue (B2). Seeds were 
broken with a cutting mill to enable the removal of seed oil. The ethanol extraction of the SF-
CO2-extraction residue was carried out with 70% ethanol in water, by a similar batch 
procedure as previously used by Sandell et al. (2009) to obtain further residue (B3). Glucose 
(50 g) was served blended into the yoghurt with dried and ground berries or berry extraction 
residues (meal B1; 40 g of dried and crushed sea buckthorn berries, meal B2; 32.4 g of berry 
residue extracted by SF-CO2, and meal B3; 18 g of ethanol extracted CO2-extraction residue), 
or without them (meal A, control, 200 g of natural yoghurt with 50 g of glucose). The amounts 
of fractions correspond to 200 g of fresh sea buckthorn berries. The production of the fraction 
utilized in studies IV and V are presented as a flow chart in Figure 12. 
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Figure 12: The production of the fraction utilized in studies IV and V.  
4.3. SUBJECTS 
Study subjects in all the studies were healthy humans with normal liver, kidney and thyroid 
functions, and with no history of cardiovascular disease or diabetes. In studies I, II, and V the 
study subjects had a normal weight, but in studies III and V overweight volunteers were 
recruited. The exact inclusion criteria in studies III and IV were: cholesterol 4.5-8 mmol/L, LDL-
cholesterol > 2.5 mmol/L, triacylglycerol < 4 mmol/L, glucose < 6 mmol/L, insulin < 25 mU/L, 
blood pressure < 160/99 mmHg, hemoglobin > 120 g/L (anemia), TSH 0.3-4.2 mU/L (thyroid 
function), ALT < 60 U/L (liver function), and creatinine < 115 μmol/L (kidney function). 
Exclusion criteria were pregnancy, menopause, regular smoking, previously diagnosed 
diabetes (other than gestational), thyroid, renal, hematological, or hepatic dysfunction, 
previous myocardial infarction, cardiovascular medication, treatment with lipid-lowering 
drugs, and ongoing inflammatory disease. In study V the inclusion criteria were: P-ALT < 60 
U/L, fP-creatinine < 115 μmol/L, and P-TSH 0.3–4.2 mU/L). 
In studies I and II the characteristics of the volunteers (two females and two males) were: age 
26 ± 4, and body mass index 20–25 kg/m2.  
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For study III, the characteristics of the volunteers (61 females) were: body mass index 29.3 
kg/m2 (berry group), 29.5 kg/m2 (control group), waist circumference 93.6 cm (berry group) 
92.9 cm (control group), and blood pressure 135/89 (berry group), 129/84 (control group). 
In study IV, the characteristics of the volunteers (80 females) were: body mass index 29.6 ± 2.1 
kg/m2, waist circumference 95.8 ± 8.5 cm, and blood pressure 133 ± 14.3 / 84.2 ± 7.9 mm Hg. 
In study V, the characteristics of the volunteers (10 males) were: body mass index 19.8–26.9 
kg/m2 (excluding one bodybuilder whose BMI was 30.0, AV (n=10) 23.7 ± 3.1), and waist 
circumference 95.8 ± 8.5 cm. 
4.4. LABORATORY METHODS 
Before acute meal tests (studies I, II, and V) the subjects ate a standardized evening snack with 
low flavonoid content (wheat bread, cucumber, water, and a banana) the night before the 
study visits. After a 10-hour fast, the subjects consumed either the berry meal (studies I, II, and 
meals B1, B2, and B3 in study V, see Fig. 12) or the control meal (meal A in study V). Before the 
meal, a basal sample of blood (studies II and V), urine (study I and II), and feces (study II) were 
collected, and after consumption of the breakfast, urine samples were collected for 24 h (0-4h, 
4-8h, 8-12h, 12-24h) and feces samples for 48 h (0-12h, 12-36h, 36-48h) (study II) and blood 
samples were collected at 60, 120, 240, and 480 minutes (study II), or at 30, 60, 90, 120, 180, 
270, and 360 minutes (study V). The subjects fasted during the 6-hour study days (study V) or 
were provided with standardized low-flavonol meals (studies I and II).  
In the intervention studies (III and IV) blood samples (two basal samples, as well as samples 
drawn at 10, 19, and 20 weeks in study III; sampling before and after each berry and wash-out 
period in study IV) were taken after an overnight fast (12 h) between 07:00 and 11:30 h a.m 
from each study subject. The study subjects were instructed to avoid alcohol and all 
medication for 3 days (study III) or 2 days (study IV) before sample collection. In addition, in 
study III 2 h glucose tolerance tests (50 g of glucose consumed as liquid, capillary blood 
samples drawn at 0, 30, 60, 90, and 120 min) were performed before and after the 
intervention period. Plasma, serum, and glucose tubes were centrifuged at 2200 x g for 10 min 
and the supernatant was stored at –80 °C in micro-centrifuge tubes until analyzed further.  
4.4.1. Physical measurements and clinical analyses 
In studies III and IV, the body weight of bare-foot subjects wearing light indoor clothing was 
recorded to the nearest 0.1 kg by a calibrated weighing scale (Inbody 3.0, Sunborn Saga Oy, 
Finland). Body height was recorded to the nearest 0.5 centimeter. Waist circumference was 
measured midway between the spina iliaca superior and the lower rib margin. Blood pressure 
was measured in duplicate using the automated Omron M4-I device (Omron, UK) in 
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accordance with standard procedures. ALT, GT, cholesterol, triacylglycerols, and creatinine 
were analyzed from plasma collected into lithium-heparine tubes, TNF-α, adiponectin, 
intercellular adhesion molecule (ICAM), vascular cell adhesion molecule (VCAM) and E-
selectine from plasma collected into EDTA-tubes, and TSH, insulin, and hs-CRP from serum. 
Serum total cholesterol, HDL cholesterol, LDL cholesterol, and triacylglycerols (C.V. 2.2%, 3.4%, 
3.1%, and 3.2%, respectively) were measured from blood samples by enzymatic photometric 
methods with commercial kits (Thermo Clinical Labsystems Oy, Espoo, Finland) using the 
Konelab20i analyser (C.V. 2.2%, 3.4%, 3.1%, and 3.2%, respectively). Plasma glucose (C.V. 
2.6%) was analyzed by the enzymatic photometric method using Konelab Glucose HK as a 
reagent. ALT, γ-glutamyltransferase (GGT), glycated haemoglobin, and serum high-sensitive 
CRP were analyzed with routine standardized methods (C.V. 4.3%, 3.1%, 4.6 % and 5.3%, 
respectively), all with a Konelab20i analyser (Thermo Clinical Labsystems Oy, Konelab, Finland) 
and TSH (C.V. 6.0%) was analyzed using Axsym (Axsym, Abbot Diagnostics, Finland). Serum 
insulin (C.V. 7.3%) was analyzed by chemiluminescence-immunoassay with a Immulite 1000 
analyser (Siemens Medical Solutions, Espoo, Finland). Haematological parameters were 
measured with a CellDyn analyser. Soluble adhesion molecules sICAM-1, (C.V. 6.6 %), sVCAM-1 
(C.V. 6.7%) and adiponectin (C.V. 3.3%) were simultaneously measured from the plasma 
samples with Millipore’s Human CVD1-kit (HCVD1-67AK) and TNF-a (HCYTO-60K) with 
Millipore’s singleplex kit (Millipore, Billerica, MA) using the BioRad Bio-Plex 200 System. 
In addition, in study III finger-prick capillary blood samples were collected intoMiniCollect 0.5 
mL lithium heparin tubes and glucose, insulin and glucose-dependent insulinotropic peptide 
(GIP) were analyzed from plasma samples by the enzymatic photometric method. Also, in 
study III the oxygen radical absorbing capacity (ORAC, C.V. 4.6%) was analyzed from serum 
using a multi-well plate reader according to the methods previously described (Venojärvi et al. 
2008). Hemoglobin A1c (HbA1c) and blood cell count analysis was performed from fresh 
blood collected into EDTA-tubes by an immunoturbidimetric method. 
In study V, blood samples were drawn from the forearms of each subject into glucose tubes 
(VF-053SFX, for glucose analysis, Oriola, Helsinki, Finland), and serum tubes containing a 
coagulant activator (VF-054 SPW, Oriola). Plasma glucose, and serum insulin were analyzed 
with standard biochemical analyses at Turku University Hospital Laboratory. Plasma glucose 
was determined by a photometric method and serum insulin by an electro-chemiluminescence 
immunoassay (TYKSLAB, Turku, Finland). Insulin was measured from a single tube with a Roche 
Modular PPEE analyzer, with commercial reagents provided by Roche Diagnostics GmbH 
(Mannheim, Germany). TNF-α was analyzed from plasma collected into EDTA-tubes with a 
Millipore’s singleplex kit (VF-054 SPW, Oriola) according to the manufacturer’s instructions, 
using the BioRad Bio-Plex 200 System. TNF-α analyses were performed only for the baseline 
and for the 60 min samples drawn after meals B1 and A. 
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4.4.2. Analysis of flavonoids by liquid chromatography and mass spectrometry 
In absorption studies the urine (I and II), feces (II) and plasma (II) samples were analyzed for 
their anthocyanin (I) and flavonol glycoside (II) content.  
For urine anthocyanin (I) and flavonol (II) analysis 2 mL of urine was acidified with 200 μL of 
0.44 M TFA (trifluoroacetic acid) in water and stored at -80 °C until analyzed (36). Acidified 
urine was purified with solid phase extraction. 96-well plates with 2 mg of Oasis® packing 
material were pre-treated with 200 μL of methanol and 200 μL of 0.1 % TFA in water. 500 μL 
of acidified methanol extract of urine (I, II), feces (II) or plasma (II) was added and 
subsequently washed with 200 μL of 0.1 % TFA in water. After this, the waste container was 
replaced with a collection plate and anthocyanins (I) and flavonol glycosides (II) were eluted 
with 25 μL of 0.1 % TFA in methanol. 25 μL of 0.1 % TFA in water was added to enhance the 
chromatographic behaviour of anthocyanins.  
The samples were injected directly from the collection plate wells into the uHPLC system. All 
MS-analyses were carried out on an uHPLC-MS/MS-equipment consisting of an Acquity UPLC™ 
system (Waters) with Acquity UPLC™ BEH C18 column (1.7 µm, 2.1 x 50 mm, Waters) and of 
Quattro Premier triple quadrupole mass spectometer (Waters). Elution for anthocyanin 
analysis (I) was performed using 0.2 % TFA and 1 % HCOOH in water as solvent A and 0.2 % 
TFA and 1 % HCOOH in acetonitrile as solvent B. For flavonol glycoside analysis (II) elution was 
performed using 1% acetic acid in water as solvent A and acetonitrile as solvent B. The 
gradient was optimized to achieve baseline separation of analytes. In study I, initial solvent 
composition for 0.45 min was 95% A and 5% B. Subsequently, the compounds were eluted 
with a gradient from 0.45 min to 6.8 min resulting in 88% A and 12% B. After that the 
proportion of B was increased to 90% for column wash and the initial conditions were 
stabilized at 7.6-8.0 min. The gradient in study II was the following: initial solvent composition 
for 0.45 min was 90% A and 10% B. Subsequently, the compounds were eluted with a gradient 
from 0.45 min to 2 min resulting in 82.5% A and 17.5% B. After that the proportion of B was 
increased to 70% for column wash and the initial conditions were stabilized at 4.8-5.3 min. The 
flow rate in both studies was 0.45 mL/min.  
Identification of anthocyanins and flavonol glycosides in plasma, urine and feces samples was 
performed by spiking blank urine with reference compounds and comparing their retention 
times and parent and product ions in MS/MS. Detection was carried out by using electrospray 
ionization in a positive ion mode. Anthocyanins were quantified with an external standard. 
Cyanidin-3-galactoside was chosen as a standard compound and a standard curve was made 
by spiking anthocyanin-free blank urine with 0, 10, 25, 100 and 500 ng/m/L cyanidin-3-
galactoside. Flavonols were quantified with an internal standard, syringetin-3-O-glucoside. To 
eliminate the error from differences in response, a standard curve was made by spiking 
flavonol-free blank urine with 0, 40, 200, 1000 and 5000 ng/mL of all reference compounds 
used (cyanidin, cyanidin 3-O-glucoside, cyanidin 3-O-galactoside, and cyanidin 3-O-rutinoside 
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in study I; isorhamnetin-3-glucoside, isorhamnetin-3-rutinoside, kaempferol-3-glucoside, 
kaempferol-3-rutinoside, quercetin-3-rhamnoside, quercetin-3-galactoside, quercetin-3-
glucoside, myricetin-3-rhamnoside and syringetin-3-glucoside in study II). In the quantification 
of compounds for which the reference compounds could not be obtained, a standard curve of 
the most similar compound was utilized. 
In studies I, II, and V, the study products were analyzed for their flavonol glycosides. The berry 
product (0.2 g) was weighed, homogenized, and extracted once with 4 mL of 0.1% TFA-H2O 
and twice with 1 mL of 0.1% TFA-MeOH. Supernatants were combined and diluted with 8 mL 
of 0.1% TFA-H2O. Extracts were applied in Supelco (C18 500 mg) solid phase extraction tubes 
(Bellefonte, USA) preconditioned with 2 mL of methanol and 2 mL of 0.1% TFA-H2O. The tubes 
were washed with 2 mL of 0.1% TFA-H2O and the analytes were eluted with 1 mL of TFA-
MeOH-H2O (40% of 0.1% TFA-H2O, 60% MeOH). The samples were analyzed as such with the 
uHPLC-MS/MS method. uHPLC-MS/MS equipment consisted of an Acquity UPLC™ system with 
a 50 mm x 2.1 mm, 1.7 μm, Acquity UPLC BEH C18 column and a Quattro Premier tandem 
quadrupole mass spectrometer (Waters, Milford, MA). The elution of the samples was 
performed using 1% acetic acid in water as solvent A and acetonitrile as solvent B. The flow 
rate was 0.45 mL/min, and the gradient was similar to the one used in the physiological 
sample analysis in study II (described above). Analysis was carried out by using electrospray 
ionization in the positive ion mode. The MS/MS data were collected in the MRM mode. In 
study I quantification was performed with external standard (cyanidin-3-galactoside), whereas 
in studies I and IV flavonols were quantified with internal standard (syringetin-3-glucoside) 
4.5. STATISTICAL ANALYSES 
In study III, group comparison analyses were calculated with an unpaired t-test when data was 
normally distributed and with the Mann-Whitney nonparametric test when data was 
abnormally distributed. Two-sided tests and significance levels of 0.05 were used throughout. 
Correlations between relative changes of measured parameters and berry consumption were 
calculated with the Spearman correlation coefficient. In study V, insulin responses were 
expressed as the incremental area under the curve (iAUC) with the fasting concentration as a 
baseline. Also, the peak values of insulin and glucose at 30 min, and the values of insulin at 
120 min, and TNF-α at 60 min were used for statistical analyses. A general linear model 
repeated measurements variance analysis was used for all results as they were normally 
distributed. In study IV, the changes in the parameters after berry interventions were 
calculated by a reduction of  the average of two wash-out values (one of the samples taken 
before the berry intervention and the other one taken after another 35 d wash-out following 
the berry intervention) from the value obtained at the end of the berry intervention.  A 
general linear model repeated measurements variance analysis was used for all results to 
compare the changes in different berry interventions to the average change of all different 
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wash-out periods. All analyses were performed with SPSS software (SPSS Inc., Chicago, IL), 
version 14.0.  
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5. RESULTS AND DISCUSSION 
5.1. ABSORPTION AND METABOLISM OF FLAVONOL GLYCOSIDES IN  
NORTHERN BERRIES  
Method development and optimization was successful althought pH-labile anthocyanins 
possessed a tricky target. The uHPLC-MS/MS run of nine minutes utilizing small solvent 
volumes together with small 96-well plate solid phase extraction columns made the method 
economical and environmentally responsible. Utilization of small solid phase extraction 
columns also enabled the simultaneous extraction, purification and concentration of 
anthocyanins from urine samples without evaporation steps.  
In study I, cyanidin-3-galactoside was the major anthocyanin in lingonberries consumed by the 
subjects (92.3% (w/w)), cyanidin-3-glucoside (7.7% (w/w)) being the minor one. Of the total 
anthocyanin derivatives obtained from urine after lingonberry ingestion, 46.7% was intact 
cyanidin-3-galactoside, 30.7% was peonidin galactoside and 22.6% was in the glucuronidated 
form. The total excreted amount of cyaniding-3-galactoside in the urine was less (AUC 1019 
ng) than the amount of its two metabolites combined (AUC 1274 ng).  
The main metabolites detected were glucuronidated and methylated derivatives of cyanidin, 
which is in accordance with previous animal (Ichiyanagi et al. 2005, Wu et al. 2004) and human 
(Talavéra et al. 2005, Wu et al. 2002, Kay et al. 2005, Kay et al. 2004) studies carried out with 
pure cyanidin compounds or extracts rich in cyanidins. Thus, the results suggest that cyanidin-
3-galactoside is absorbed and metabolized by similar routes to other cyanidin glycosides 
investigated to date, althought relative amounts of intact and metabolized forms were 
somewhat different than previously reported. The maximum concentration of cyanidin 
derivatives in the urine after the ingestion of lingonberries with yoghurt appeared slightly later 
than reported in earlier cyanidin absorption studies (Bitsch et al. 2004, Frank et al. 2007, Frank 
et al. 2003, McGhie et al. 2003). In these studies, cyanidin glycosides were ingested in the form 
of an extract or concentrated juice. It is interesting to note that anthocyanins in our study 
design also remained in the urine longer, even up to 12 hours. We also detected lower 
maximum concentrations of individual anthocyanins in the urine compared with many 
previous studies. Lower peak concentration is evidently a consequence of the slower 
absorption.  
Also, the relative amounts of intact and metabolized forms were somewhat different than 
previously reported. In study I, of the total anthocyanin derivatives obtained from the urine 
46.7 % was intact cyanidin-3-galactoside, 30.7 % was peonidin galactoside and 22.6 % was in a 
glucuronidated form (Fig. 13). 































Figure 13: The amounts of total anthocyanin derivatives obtained from urine. 46.7 % was intact cyanidin-
3-galactoside (squares ), and 53.3 % was metabolized (dots • ).  
In study II, the HPLC-MS/MS method was further optimized for flavonol glycoside analysis. Run 
time of 5.3 min made the method ecological as solvent usage was minimal. Detection and 
quantification limits for the reference compounds were 0.75 ng/mL and 1.5–3.1 ng/mL in 
standard dilutions, respectively. Isorhamnetin-3-rutinoside was the major flavonol in sea 
buckthorn berries [54% (wt-%)], isorhamnetin-3-glucoside, isorhamnetin-3-galactoside and 
quercetin-3-glucoside being the minor ones, accounting for 22, 8, and 13% (wt-%, 
respectively). In lingonberries quercetin-3-rhamnoside was the main flavonol [33% (wt-%)], 
and quercetin-3-galactoside, quercetin-3-glucoside, and quercetin-3-xyloside/-arabinoside 
were present as lower levels of 29, 4, 6, 5, and 19% (wt-%, respectively) of the total flavonols.  
After the consumption of sea buckthorn, 5.1% of flavonols excreted in the urine were detected 
intact, and 94.9% as the glucuronidated form. Isorhamnetin-3-rutinoside, isorhamnetin-3-
glucoside, quercetin-3-glucoside and kaempherol-3-rutinoside were detected in feces, 
isorhamnetin-3-glucoside, quercetin-3-glucoside, isorhamnetin glucuronide and quercetin 
glucuronide in the urine and isorhamnetin glucuronide and kaempherol glucuronide in the 
plasma. Lingonberry meal resulted in somewhat different proportions of intact and 
glucuronidated forms as 13.8% of flavonols analyzed from the urine were glycosides, and 
86.2% glucuronidated forms. After the consumption of lingonberries, quercetin-3-galactoside, 
quercetin-3-rhamnoside, and quercetin-3-x-sugar were detected in the feces, quercetin-3-x-
sugar, quercetin glucuronide, quercetin-3-rhamnoside in the urine and quercetin-3-
rhamnoside, quercetin glucuronide and kaempherol glucuronide in the plasma. Compounds 
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detected after the consumption of lingonberry and sea buckthorn were not detectable before 
the consumption of the berries, and the concentrations decreased in plasma and urine almost 
to the baseline values during the collection period. For feces the 48 h collection period was too 
short as the analytes were detectable at the 48 h timepoint. Amounts of glucuronides and 
glycosides in urine are presented in Figure 14. Berries thus seem to serve as foods or food 
components providing a relatively slow and steady flavonol supply, when compared to 















Figure 14: Concentrations of flavonol glucuronides and glycosides in urine analyzed in study II after the 
consumption of a berry breakfast. sb= sea buckthorn, lb=lingonberry 
However, Interindividual differences both at the absorption extent and time as well as relative 
proportions of different metabolites were large. The concentrations of intact compounds and 
metabolites in the urine of individual study subjects is presented in Figure 15. As a summary, it 
can be stated that both anthocyanins and flavonol glycosides ingested in the studied berries 
are absorbed and the absorbed compounds are vastly metabolized. Metabolites tend to be in 
the more easily soluble and excreted form, i.e. in glucuronides. 
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Figure 15: Concentrations of isorhamnetin-3-glucoside in the urine samples of the four study subjects 
after the ingestion of sea buckthorn. 
5.2. EFFECT OF NORTHERN BERRIES ON ECTOPIC FAT ACCUMULATION 
AND THE RISK OF OBESITY-RELATED DISEASES 
In study III, plasma ALT decreased and plasma adiponectin increased in the berry group 
(P<0.001 and P=0.002, respectively), but there was no statistically significant change in the 
lifestyle group. The changes in plasma ALT differed statistically significantly (P=0.003) between 
the groups (Fig. 16A). As there was a slight increasing trend in the adiponectin in the control 
group (Δ 0.56 μg/mL in control group, Δ 1.61 μg/mL in the berry group), the difference 
between the groups did not reach a level of significance. No statistically significant changes in 
either of groups were recorded in BMI, waist circumference, fasting plasma insulin levels, 
fasting plasma cholesterol or triacylglycerol levels, hs-CRP, TNF-α or ORAC. 
Changes in the ALT activities of the individual study subjects in the berry group in study III 
displayed a decreasing trend in 24 subjects out of 28 (Fig. 16B), whereas changes in the 
lifestyle group were random (data not shown). This supports the conclusions drawn from the 
statistical results. Because ALT is affected by alcohol consumption, the average intake of 
alcohol of the study subjects was estimated from food diaries and compared between the 
groups. There was no difference in the average alcohol consumption (P=0.973), and neither in 
the compliance to alcohol restriction before the sample collection, between the groups.  
Changes of adiponectin and ALT correlated negatively and statistically significantly (P=0.049, 
R=0.08) when all the study subjects were taken into account. Within the berry group there was a 
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significant correlation between berry consumption and both an adiponectin increase (P=0.021, 
R=0.204) and an ALT decrease (P=0.039, R=0.159). Slight variation in berry consumption within the 
berry group explained 20.4 % of the adiponectin increase and 15.9 % of ALT decrease during 
intervention, although berry intake in this group was already very high. Within the lifestyle group 
there was no correlation between the reported berry consumption and ALT and adiponectin 
changes. Thus it can be stated that berries probably caused the decrease of ALT values and the 
increase of the adiponectin values in the berry group. The current study showed that the daily 
consumption of over 150 g of northern berries in various forms as part of the normal diet had a 
positive effect on ALT and adiponectin levels, but the small amount of berries consumed as part of 
the normal diet in the lifestyle group was not enough to evoke such an impact. 
The decrease in ALT activity in the berry group was 23%. Ratziu et al. (2010) recently reported in 
their study on rosiglitazone, a decrease of 24% both after 4-6 months and even a 2 year extension 
phase. As rosiglitazone is a medication with many side effects, it is remarkable that the same effect 
could be obtained by eating safe and traditional berries. 


















































Figure 16: The changes in plasma ALT on average in both groups (A), and the changes of individual study 
subjects in the berry group (B). 
In study IV, VCAM concentrations decreased after BB and SBo diets, and ICAM after a SBe diet. 
Also, the values not reaching statistical significance tended to show a decreasing trend after 
other berry intervention periods in VCAM and ICAM values. ICAM and VCAM belong to the 
immunoglobulin super-family, and they are involved in the process of tethering leukocyte to 
and transmigration across the endothelium (Konstantopuolos et al. 1996). Firm adhesion and 
transmigration of leucocytes across the endothelium requires ICAM and VCAM, and this step is 
the earliest stage in the development of the atherosclerotic lesion. Thus, these endothelial 
markers are implicated in the pathogenesis of atherosclerosis and CVD (Hope et al. 2003), and 
they are also elevated in obesity and have been shown to decrease with weight loss (Keogh et 
al. 2007). Major change observed in study IV, both statistically significant and more profound 
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in subjects with greater baseline BMI, was the decrease in VCAM levels during sea buckthorn 
berry oil intervention. Also, statistically significant changes in waist circumference after BB (Δ -
1.2 cm, p = 0.041) and SB (Δ -1.1 cm, p = 0.008) periods were observed. A decreasing but non-
significant trend was observed also after the other berry interventions, [SBo (Δ -1.2 cm ± 3.8, 
NS, p = 0.077) and SBe (Δ -0.1 cm ± 4.1, NS)]. Accordingly, there was a small decrease in 
weight after the BB diet (Δ -0.2 kg, p = 0.028) but after the SBe and SBo interventions the 
decrease was statistically non-significant. 
It must be noted that energy intake during the SB diet was higher than in wash-out periods, 
mainly due to increased carbohydrates, mostly sugar, and fat intake from other sources than 
the berry itself. These changes were due to other modifications of the diet that occurred 
during the SB period, possibly because of the strong taste of the berry. It seems that study 
subjects increased the use of sugar- and fat-rich foods, although the energy intake was 
intended to be similar. This might have hindered some effects of the SB diet and explains 
why SBo and SBe diets had more impact on VCAM and ICAM values than the whole berry 
(SB) diet. It is also interesting to notice that BB seemed to be more effective than SB, 
although previously isorhamnetin-3-glucuronide, a major metabolite of isorhamnetin 
glucosides of sea buckthorn, has been shown to modulate the expression of VCAM (Tribolo 
et al. 2008). Also aronia (Aronia melanocarpa E.) extract has been shown to lower the levels 
of adhesion molecules concurrently with IL-6 and CRP, and the elevation of adiponectin 
(Naruszewicz et al. 2007).  
Adiponectin is an adipose-secreted cytokine, which is present at decreased plasma levels in 
subjects with obesity (Arita et al. 1999) or type 2 diabetes (Hotta et al. 2000). According to a 
recent review, experimental and epidemiological studies have provided abundant evidence 
that adiponectin improves insulin sensitivity, and has potent antiatherosclerotic effects (Stefan 
et al. 2002). In study III, adiponectin increased during a mixed berry diet, although the 
differences between the berry and lifestyle groups was not statistically significant. In study IV, 
adiponectin was decreased more or less during all berry interventions. This contradiction 
seems less confusing in the light of the knowledge that adiponectin values (Arita et al. 1999), 
similarly to GHbA1c (American Diabetes Association 2003), change more slowly than, for 
example, ICAM and VCAM values. The rate of formation of GHbA1c is directly proportional to 
the ambient glucose concentration. Since erythrocytes are freely permeable to glucose, the 
level of GHbA1c in a blood sample reflects the glycemic control of the previous 120 days, the 
average erythrocyte life span (American Diabetes Association 2003). As the duration of 
intervention periods was only 33-35 days, the changes observed in GHbA1c and adiponectin 
values may reflect more the effect of wash-out periods than the berry intervention and vice 
versa. In any case, when considering the nature of the formation of GHbA1c, intervention 
periods in this study were quite short (5 weeks) to make strong conclusions.  
There was no decrease in ALT activity after any intervention period in trial IV. Thus it seems 
that the effects observed in study III cannot be due to bilberry or sea buckthorn. It also 
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seems that either lingonberry and/or black currant modulate the fat metabolism of the liver 
into a positive direction or the positive effect requires simultaneous incorporation of 
different berries into the diet. However, it must be noted that there were also other 
differences between trials III and IV as intervention periods in the latter (IV) were shorter (5 
weeks instead of 20), and the daily amount of berries less (100 g instead of 160 g). However, 
sampling was performed also at the 10-week time point in trial III, and the change in ALT 
values was already at the same level as after 20 weeks. This implies that some trend could 
be expected already after 5 weeks in this particular value. Another notion should be made 
about sea buckthorn varieties, as in the first trial berries were consumed frozen and were 
the organically cultivated Ljubitelskaja variety (Hippophaë rhamnoides ssp mongolica) 
grown in Finland, whereas in the second trial, sea buckthorn berries were dried Hippophaë 
rhamnoides ssp turkestanica berries grown in China. Despite the lack of decline in ALT 
values, trial IV showed the other positive effects of berries on the risk factors of obesity-
related diseases. Based on the results, it can be stated that different berries and berry 
fractions have quite different effects on metabolic syndrome and type 2 diabetes risk 
factors. 
5.3. EFFECT OF SEA BUCKTHORN AND ITS FRACTIONS ON THE 
POSTPRANDIAL GLUCOSE METABOLISM  
The main flavonol glycosides in the products were isorhamnetin-3-rutinoside, -glucoside, and –
galactoside. One portion contained 22.8 mg (B1), 68.0 mg (B2), and 1.8 mg (B3) of flavonol 
glycosides. Whole berry meal (meal B1) in study V had a balancing effect on postprandial 
hyperglycemia when compared to the control meal (meal A) (∆ glucose concentration of 30 
min peak value – 120 min value -1.0 mmol/L, p=0.042 versus the values in control meal). Also 
the insulin peak concentrations were lower after meal B1 than after meal A (∆ insulin 
concentration of 30 min peak value between the meals -22 mU/L, p = 0.039). The differences 
between meals B1 and A were even greater when the 120 min value was also considered, 
because the berries suppressed the subsequent drop in insulin values after the peak 
concentration (∆ insulin concentration of 30 min peak value – 120 min value between the 
meals -30.4 mU/L, p = 0.036). The phenomenon could also be observed as a trend of lower 
iAUC values (∆iAUC30 min of insulin between the meals -297.2, p=0.062, ∆iAUC120 min of insulin 
between the meals -363.1, p=0.507). Similarly, the oil-free berry meal (meal B2, see Fig 12 for 
the production flow of berry fractions) had a positive effect on insulin metabolism (∆ 
concentration of 30 min peak value – 120 min value -25.9 mU/L, p=0.037). In contrast, the 
berry residue (meal B3) had no effect on the peak insulin concentration, and the iAUC of 120 
minutes was even slightly higher than of the control meal. Postprandial insulin responses after 
each berry meal and control meal are presented in Figure 17. 
























Figure 17: Postprandial insulin responses after each berry meal and control meal. A=control meal, 
B1=whole sea buckthorn meal, B2= oil-free berry meal and B3= berry residue. For production flow, see 
Fig 12. 
Removal of the lipophilic compounds (SBo in Fig. 12) did not affect the advantageous effects of 
the berries on insulin metabolism (p=0.608) but the removal of the fraction soluble in 70 % 
EtOH (SBe in Fig. 12) eliminated the observed effects. The effective compounds seem thus to 
be in the ethanol soluble fraction rather than in the lipophilic fractions. However, it must be 
noted that meal B2 had higher content of flavonol glycosides than meal B1 when analyzed by 
HPLC-MS/MS. Amounts of different products in one meal had to be estimated before flavonol 
analysis results were obtained, and thus the erraneous approximation of extraction efficiency 
resulted in higher content of flavonol glycosides in the extract than whole berry. 
Elevated plasma glucose concentrations are thought to alter metabolism, create oxidative 
stress, and induce apoptosis in many cell types (Evans et al. 2002). Oscillating glucose has been 
shown to be an even more important risk factor of metabolic diseases and their further 
complications than the mean glucose (Ceriello et al. 2008). The rapid absorption of glucose 
challenges the homeostasis mechanisms of the body, complicating in effect the transition from 
the postprandial state to the postabsorptive state (Wolever et al. 1995). The effect of 
carbohydrate composition on postprandial hyperglycemia and postprandial insulin response is 
commonly accepted (Kallio et al. 2008, Ludwig, 2000). Yet, even though there is some 
emerging evidence of the ability of other than macronutrient components of food to alter 
postprandial sugar metabolism, such evidence is to date scarce and mainly produced by in 
vitro and animal trials. Some exotic fruits or their phenolic extracts have also shown positive 
effects on sugar metabolism in animal models, as Zunino (2009) recently reviewed. However, 
prior to study V of this thesis, no investigations were available concerning the potential of 
northern berries to alter postprandial metabolism. In study V, sea buckthorn berries had a 
stabilizing effect on postprandial hyperglycemia. Furthermore, these berries suppressed the 
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peak postprandial insulin response after a high-glucose meal. Thus, sea buckthorn berries 
consumed as part of a high-glucose meal containing simple carbohydrates seemed to be able 
to modify the postprandial glucose metabolism towards a metabolic response typical after 
ingestion of complex carbohydrates. 
The berries as part of a high-glucose meal containing simple carbohydrates seemed to be able 
to modify the postprandial glucose metabolism towards a metabolic response typical after 
ingestion of complex carbohydrates. In addition, the insulin response was milder compared to 
the control, and this was also observed with the ethanol extract of sea buckthorn (V). 
According to accumulating evidence, diets designed to lower the insulin response to ingested 
carbohydrates may improve access to stored metabolic fuels, decrease hunger, and promote 
weight loss (Brand-Miller et al. 2002).  
As a summary, it can be concluded that polyphenols possess the potential for decreasing the 
risk of metabolic dysfunctions, and alleviating ectopic fat accumulation. In the future, the 
potential of lingonberry and black currant on ectopic fat accumulation should be studied in 
clinical trials. It is also highly recommendable to perform another larger clinical trial with 
mixed berries. Berries are ecologic northern resources, the potential of which should be noted 
and utilized. Safe, natural alternatives for medication are especially important in the fight 




An alarming trend in developed countries is that obesity, metabolic syndrome and type 2 
diabetes are developing at increasingly younger ages (Franks et al. 2010). The potential of 
berries to decrease the risk of these ailments could be of primary importance for children and 
adolescents as berries are safe and readily accepted by them. In the original research of this 
thesis, the aim was to study whether berries could have positive effects on the risk factors of 
obesity-related diseases.  
In the first part of the research (studies I, II) a high performance liquid chromatography 
tandem mass spectrometry analysis of anthocyanins and flavonol glycosides was developed, 
optimized and applied in a small postprandial trial. Both anthocyanins and flavonl glycosides of 
berries were shown to be bioavailable and metabolized in humans.  
In the second part, a mixed berry diet was shown to decrease ALT values in a 5-month 
intervention study in humans, suggesting a eduction in liver fat content (III). This effect was 
not there when sea buckthorn and bilberry were consumed for 5 weeks, although other 
positive changes in waist circumference and adhesion molecules were seen (IV). It might be 
that a synergistic effect of various berries is needed to affect the ALT values related to ectopic 
fat accumulation, or the intervention time needs to be longer than 5 weeks. An explanation 
can also be that one of the berries not used in study IV, lingonberry or black currant, is the 
most active. However, it can be concluded that berries have various but positive effects on the 
risk factors of obesity-related diseases.  
The third aim was to study the effects of sea buckthorn berry on the postprandial glucose 
metabolism. Study V showed that sea buckthorn berries decreases the postprandial 
hyperglycemia and insulinemia induced by a high-glucose meal. The effects could be mainly 
traced down to the polyphenol-rich fraction of the berry. 
Although the compounds behind the the observed effects could not be revealed, some 
suggestions could be made. As polyphenolic fraction seemed to be the most active one in the 
modulation of postprandial sugar metabolism (V), it could be postulated to be the active 
fraction also in study III. In the literature review, the complex mechanisms behind ectopic fat 
accumulation were introduced with an emphasis on the possible control points where 
bioactive compounds could exert their regulatory effects. Based on the literature review, 
tannins seem to be one of the compound groups with the most potential. This supports the 
conclusion made based on the results from studies III and IV, that of the studied berries the 
one berry with most potential in alleviating ectopic fat accumulation is probably lingonberry or 
black currant, both berries being rich in tannins. However, it must be noted that the most 
investigated tannins are hydrolyzable tannins found in green tea, and the most abundant 
tannins in berries are often condensed tannins. 
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